Pall 10-Q 3 Mar 14 2014 Q2 Quarterly report Financial data

DOCUMENT_AND_ENTITY_INFORMATIO

DOCUMENT AND ENTITY INFORMATION	6 Months Ended
	Jan. 31, 2014	Feb. 26, 2014
Entity Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	31-Jan-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'
Entity Registrant Name	'PALL CORP	'
Entity Central Index Key	'0000075829	'
Current Fiscal Year End Date	'--07-31	'
Entity Well-known Seasoned Issuer	'Yes	'
Entity Voluntary Filers	'No	'
Entity Current Reporting Status	'Yes	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	109,775,816

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Jan. 31, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$951,834	$936,886
Accounts receivable	536,755	566,335
Inventory	394,865	381,047
Prepaid expenses	74,471	72,808
Other current assets	80,924	92,953
Total current assets	2,038,849	2,050,029
Property, plant and equipment	789,342	774,948
Goodwill	348,080	342,492
Intangible assets	137,385	137,243
Other non-current assets	159,858	168,127
Total assets	3,473,514	3,472,839
Current liabilities:	'	'
Notes payable	304,930	169,967
Accounts payable	134,295	157,176
Accrued liabilities	284,099	312,829
Income taxes payable	53,535	60,732
Current portion of long-term debt	405	420
Dividends payable	0	27,947
Total current liabilities	777,264	729,071
Long-term debt, net of current portion	463,674	467,319
Income taxes payable – non-current	145,905	141,843
Deferred taxes and other non-current liabilities	339,643	319,650
Total liabilities	1,726,486	1,657,883
Stockholders’ equity:	'	'
Common stock, par value $.10 per share	12,796	12,796
Capital in excess of par value	295,106	298,150
Retained earnings	2,397,826	2,285,031
Treasury stock, at cost	-943,739	-740,229
Accumulated other comprehensive income/(loss):	'	'
Foreign currency translation	105,887	84,598
Pension liability adjustment	-125,876	-125,211
Unrealized investment gains	1,749	2,123
Unrealized gains/(losses) on derivatives	3,279	-2,302
Total accumulated other comprehensive income/(loss)	-14,961	-40,792
Total stockholders’ equity	1,747,028	1,814,956
Total liabilities and stockholders’ equity	$3,473,514	$3,472,839

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Jan. 31, 2014	Jul. 31, 2013
Statement of Financial Position [Abstract]	'	'
Common stock, par value per share (in dollars per share)	$0.10	$0.10

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Income Statement [Abstract]	'	'	'	'
Net sales	$676,969	$662,455	$1,306,748	$1,290,055
Cost of sales	332,710	320,492	636,775	621,009
Gross profit	344,259	341,963	669,973	669,046
Selling, general and administrative expenses	196,299	206,009	391,183	401,974
Research and development	24,979	23,399	48,246	45,974
Restructuring and other charges, net	9,170	4,399	18,368	8,673
Interest expense, net	5,195	6,017	11,172	5,449
Earnings from continuing operations before income taxes	108,616	102,139	201,004	206,976
Provision for income taxes	24,950	21,820	45,825	37,492
Net earnings from continuing operations	83,666	80,319	155,179	169,484
Earnings/(loss) from discontinued operations, net of income taxes	0	-3,549	0	246,758
Net earnings	$83,666	$76,770	$155,179	$416,242
Earnings per share from continuing operations:	'	'	'	'
Basic (in dollars per share)	$0.76	$0.71	$1.39	$1.49
Diluted (in dollars per share)	$0.75	$0.70	$1.38	$1.48
Earnings/(loss) per share from discontinued operations:	'	'	'	'
Basic (in dollars per share)	$0	($0.03)	$0	$2.18
Diluted (in dollars per share)	$0	($0.03)	$0	$2.15
Earnings per share:	'	'	'	'
Basic (in dollars per share)	$0.76	$0.68	$1.39	$3.67
Diluted (in dollars per share)	$0.75	$0.67	$1.38	$3.63
Dividends declared per share	$0	$0.25	$0.28	$0.50
Average shares outstanding:	'	'	'	'
Basic	110,720	112,420	111,263	113,398
Diluted	111,980	113,809	112,532	114,784

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Statement of Comprehensive Income [Abstract]	'	'	'	'
Net earnings	$83,666	$76,770	$155,179	$416,242
Other comprehensive income/(loss), net of income taxes:	'	'	'	'
Foreign currency translation	-21,938	7,570	21,289	41,322
Pension liability adjustment	-71	3,375	-665	4,563
Unrealized investment gains/(losses)	-292	-344	-374	63
Unrealized gains/(losses) on derivatives	3,126	-1,825	5,581	-3,777
Total other comprehensive income/(loss), net of income taxes	-19,175	8,776	25,831	42,171
Comprehensive income	$64,491	$85,546	$181,010	$458,413

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013
Operating activities:	'	'
Net cash provided by operating activities	$205,595	$89,382
Investing activities:	'	'
Capital expenditures	-34,663	-42,403
Acquisition of businesses	-5,299	0
Purchases of retirement benefit assets	-14,312	-28,166
Proceeds from retirement benefit assets	19,946	30,322
Proceeds from sale of assets	1,953	542,088
Other	-3,278	-1,094
Net cash provided/(used) by investing activities	-35,653	500,747
Financing activities:	'	'
Notes payable	134,963	30,024
Dividends paid	-58,408	-52,634
Long-term borrowings	0	15
Repayments of short-term debt	-3,927	0
Repayments of long-term debt	-375	-239
Net proceeds from stock plans	7,130	24,623
Purchase of treasury stock	-250,000	-250,000
Excess tax benefits from stock-based compensation arrangements	9,444	8,426
Net cash used by financing activities	-161,173	-239,785
Cash flow for period	8,769	350,344
Cash and cash equivalents at beginning of year	936,886	500,274
Effect of exchange rate changes on cash and cash equivalents	6,179	19,614
Cash and cash equivalents at end of period	951,834	870,232
Supplemental disclosures:	'	'
Interest paid	11,844	22,612
Income taxes paid (net of refunds)	$31,772	$103,876

BASIS_OF_PRESENTATION

BASIS OF PRESENTATION	6 Months Ended
	Jan. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
BASIS OF PRESENTATION	'
	BASIS OF PRESENTATION
	The condensed consolidated financial information of Pall Corporation and its subsidiaries (hereinafter collectively called the “Company”) included herein is unaudited. Such information reflects all adjustments of a normal recurring nature, which are, in the opinion of Company management, necessary to present fairly the Company’s consolidated financial position, results of operations and cash flows as of the dates and for the periods presented herein. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2013 (“2013 Form 10-K”).
	As discussed in Note 16, Discontinued Operations, on August 1, 2012, the Company sold certain assets of its blood collection, filtration and processing product line, which was a component of the Company’s Life Sciences segment, and met the criteria for discontinued operations and held for sale presentation during the third quarter of fiscal year 2012. As such, it has been reported as a discontinued operation in the Company’s condensed consolidated financial statements for all periods presented.

BALANCE_SHEET_DETAILS

BALANCE SHEET DETAILS	6 Months Ended
	Jan. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
BALANCE SHEET DETAILS	'
	BALANCE SHEET DETAILS
	The following tables provide details of selected balance sheet items:
		Jan 31, 2014			Jul 31, 2013
	Accounts receivable:
	Billed	$	482,809		$	508,448
	Unbilled	67,548			72,787
	Total	550,357			581,235
	Less: Allowances for doubtful accounts	(13,602		)	(14,900		)
		$	536,755		$	566,335
	Unbilled receivables principally relate to revenues accrued for long-term contracts recorded under the percentage-of-completion method of accounting.
		Jan 31, 2014			Jul 31, 2013
	Inventory:
	Raw materials and components	$	114,702		$	94,837
	Work-in-process	105,484			94,998
	Finished goods	174,679			191,212
		$	394,865		$	381,047
		Jan 31, 2014			July 31, 2013
	Property, plant and equipment:
	Property, plant and equipment	$	1,719,826		$	1,650,274
	Less: Accumulated depreciation and amortization	(930,484		)	(875,326		)
		$	789,342		$	774,948

GOODWILL_AND_INTANGIBLE_ASSETS

GOODWILL AND INTANGIBLE ASSETS	6 Months Ended
	Jan. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
GOODWILL AND INTANGIBLE ASSETS	'
	GOODWILL AND INTANGIBLE ASSETS
	The following table presents goodwill, allocated by reportable segment.
		Jan 31, 2014		Jul 31, 2013
	Life Sciences	$	186,098	$	180,896
	Industrial	161,982		161,596
		$	348,080	$	342,492
	Intangible assets, net, consist of the following:
		Jan 31, 2014
		Gross		Accumulated		Net
				Amortization
	Patents and unpatented technology	$	112,559	$	62,044	$	50,515
	Customer-related intangibles	106,290		27,354		78,936
	Trademarks	13,353		6,573		6,780
	Other	3,638		2,484		1,154
		$	235,840	$	98,455	$	137,385
		Jul 31, 2013
		Gross		Accumulated		Net
				Amortization
	Patents and unpatented technology	$	123,707	$	69,992	$	53,715
	Customer-related intangibles	97,016		22,425		74,591
	Trademarks	13,291		6,166		7,125
	Other	4,425		2,613		1,812
		$	238,439	$	101,196	$	137,243
	Goodwill and intangible assets were primarily impacted by changes in the foreign exchange rates used to translate goodwill and intangible assets of foreign subsidiaries. Intangible assets were additionally impacted by immaterial acquisitions of Medistad Holding BV, a European manufacturing entity and SoloHill Engineering, Inc., a United States (“U.S”) technology company in the first and second quarters of fiscal year 2014, respectively.
	Amortization expense from continuing operations for intangible assets for the three and six months ended January 31, 2014 was $4,655 and $9,379, respectively. Amortization expense from continuing operations for intangible assets for the three and six months ended January 31, 2013 was $4,857 and $10,135, respectively. Amortization expense is estimated to be approximately $9,296 for the remainder of fiscal year 2014, $17,011 in fiscal year 2015, $15,744 in fiscal year 2016, $15,662 in fiscal year 2017, $15,493 in fiscal year 2018, and $13,170 in fiscal year 2019.

TREASURY_STOCK

TREASURY STOCK	6 Months Ended
	Jan. 31, 2014
Stockholders' Equity Note [Abstract]	'
TREASURY STOCK	'
	TREASURY STOCK
	The following table highlights the share repurchase authorizations in effect during fiscal year 2014:
		Date of Authorization
		26-Sep-11			17-Jan-13			Total
	Amount available for repurchases as of July 31, 2013	$	81,873		$	250,000		$	331,873
	New authorizations	—			—			—
	Utilized	(81,873		)	(168,127		)	(250,000		)
	Amount available for repurchases as of January 31, 2014	$	—		$	81,873		$	81,873
	The Company’s shares may be purchased over time as market and business conditions warrant. There is no time restriction on these authorizations. In September 2013, the Company entered into an Accelerated Share Repurchase (“ASR”) agreement with a third-party financial institution to repurchase $125,000 of the Company’s common stock. This transaction was completed in the second quarter of fiscal year 2014. Under the agreement, the Company paid $125,000 to the financial institution. Upon completion of the transaction, the Company received a total of 1,573 shares with an average price per share of $79.45.
	In December 2013, the Company entered into a second ASR agreement with a third-party financial institution to repurchase $125,000 of the Company’s common stock. Under the agreement, the Company paid $125,000 to the financial institution and received an initial delivery of 1,249 shares at an aggregate cost of $106,250, with an average price per share of $85.05. These shares were included in treasury stock in the accompanying condensed consolidated balance sheet as of January 31, 2014. The remaining $18,750 was included in additional paid in capital in the accompanying condensed consolidated balance sheets as of January 31, 2014. The December 2013 ASR agreement will be settled during the third quarter of fiscal year 2014. The final number of shares delivered upon settlement of the December 2013 ASR agreement will be determined with reference to the average price of the Company’s common stock over the term of the ASR agreement.
	During the six months ended January 31, 2014, 694 shares were issued under the Company’s stock-based compensation plans. At January 31, 2014, the Company held 18,298 treasury shares.

CONTINGENCIES_AND_COMMITMENTS

CONTINGENCIES AND COMMITMENTS	6 Months Ended
	Jan. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
CONTINGENCIES AND COMMITMENTS	'
	CONTINGENCIES AND COMMITMENTS
	With respect to the matters described in Note 14, Contingencies and Commitments, to the Company’s consolidated financial statements included in the Company’s 2013 Form 10-K and below, the Company has assessed the ultimate resolution of these matters and has reflected appropriate contingent liabilities in the condensed consolidated financial statements as of January 31, 2014 and July 31, 2013.
	The Company and its subsidiaries are subject to certain other legal actions that arise in the normal course of business. Other than those legal proceedings and claims discussed in the 2013 Form 10-K and this Note, the Company is not facing any other legal proceedings and claims that would individually or in the aggregate have a reasonably possible material adverse effect on its financial condition or operating results. As such, any reasonably possible loss or range of loss, other than those legal proceedings discussed in the 2013 Form 10-K and this Note, is immaterial. However, the results of legal proceedings cannot be predicted with certainty. If the Company failed to prevail in several of these legal matters in the same reporting period, the operating results of a particular reporting period could be materially adversely affected.
	Environmental Matters:
	With respect to the environmental matters at the Company’s Pinellas Park, Florida site, previously disclosed in Note 14, Contingencies and Commitments, to the Company’s consolidated financial statements included in the Company’s 2013 Form 10-K, the Florida Department of Environmental Protection approved the remedial action plan in September 2013. As a result of this, the Company added $4,440 to its environmental reserves in the first quarter of fiscal year 2014.
	The Company’s condensed consolidated balance sheet at January 31, 2014 includes liabilities for environmental matters of approximately $21,402 which relate primarily to the environmental proceedings discussed in the 2013 Form 10-K and as updated in this Note. In the opinion of management, the Company is in substantial compliance with applicable environmental laws and its current accruals for environmental remediation are adequate. However, as regulatory standards under environmental laws are becoming increasingly stringent, there can be no assurance that future developments, additional information and experience gained will not cause the Company to incur material environmental liabilities or costs beyond those accrued in its condensed consolidated financial statements.

RESTRUCTURING_AND_OTHER_CHARGE

RESTRUCTURING AND OTHER CHARGES, NET	6 Months Ended
	Jan. 31, 2014
Restructuring and Related Activities [Abstract]	'
RESTRUCTURING AND OTHER CHARGES, NET	'
	RESTRUCTURING AND OTHER CHARGES, NET
	The following tables summarize the restructuring and other charges (“ROTC”) recorded in the three and six months ended January 31, 2014 and January 31, 2013:
		Three Months Ended Jan 31, 2014									Six Months Ended Jan 31, 2014
		Restructuring			Other			Total			Restructuring			Other			Total
		-1			(Gains)/						-1			(Gains)/
					Charges									Charges
					-2									-2
	Severance benefits and other employment contract obligations	$	7,347		$	(844	)	$	6,503		$	10,462		$	(402	)	$	10,060
	Professional fees and other costs, net of receipt of insurance claim payments	894			2,053			2,947			2,137			2,195			4,332
	(Gain)/loss on sale and impairment of assets, net	—			—			—			—			160			160
	Environmental matters	—			—			—			—			4,440			4,440
	Reversal of excess restructuring reserves	(280		)	—			(280		)	(624		)	—			(624		)
		$	7,961		$	1,209		$	9,170		$	11,975		$	6,393		$	18,368
	Cash	$	7,961		$	1,209		$	9,170		$	11,975		$	6,233		$	18,208
	Non-cash	—			—			—			—			160			160
		$	7,961		$	1,209		$	9,170		$	11,975		$	6,393		$	18,368
		Three Months Ended Jan 31, 2013									Six Months Ended Jan 31, 2013
		Restructuring			Other			Total			Restructuring			Other			Total
		-1			(Gains)/						-1			(Gains)/
					Charges									Charges
					-2									-2
	Severance benefits and other employment contract obligations	$	1,916		$	1,451		$	3,367		$	5,195		$	1,451		$	6,646
	Professional fees and other costs, net of receipt of insurance claim payments	345			887			1,232			788			1,586			2,374
	(Gain)/loss on sale and impairment of assets, net	(49		)	—			(49		)	(6		)	—			(6		)
	Reversal of excess restructuring reserves	(151		)	—			(151		)	(341		)	—			(341		)
		$	2,061		$	2,338		$	4,399		$	5,636		$	3,037		$	8,673
	Cash	$	1,705		$	1,825		$	3,530		$	5,237		$	2,524		$	7,761
	Non-cash	356			513			869			399			513			912
		$	2,061		$	2,338		$	4,399		$	5,636		$	3,037		$	8,673
	(1) Restructuring:
	In fiscal year 2012, the Company announced a multi-year strategic cost reduction initiative (“structural cost improvement initiative”). This initiative impacts both segments as well as the Corporate Services Group. The goal of this initiative is to properly position the Company’s cost structure globally to perform in the current economic environment without adversely impacting its growth or innovation potential.
	Key components of the structural cost improvement initiative include:
	•	the strategic alignment of manufacturing, sales and R&D facilities to cost-effectively deliver high-quality products and superior service to the Company’s customers worldwide,
	•	creation of regional shared financial services centers for the handling of accounting transaction processing and other accounting functions,
	•	reorganization of sales functions, to more cost-efficiently deliver superior service to the Company’s customers globally, and
	•	reductions in headcount across all functional areas, enabled by efficiencies gained through the Company’s ERP systems, as well as in order to align to economic conditions.
	Restructuring charges recorded in the three and six months ended January 31, 2014 and January 31, 2013 primarily reflect the expenses incurred in connection with the Company’s structural cost improvement initiative as discussed above.
	(2) Other (Gains)/Charges:
	Severance benefits and other employment contract obligations: In the three months ended January 31, 2013, the Company recorded charges related to certain employment contract obligations.
	Professional fees and other: In the three months ended January 31, 2014, the Company recorded acquisition related legal and other professional fees. In the three and six months ended January 31, 2013, the Company recorded settlement related costs as well as legal and other professional fees, related to the Federal Securities Class Actions, Shareholder Derivative Lawsuits and Other Proceedings (see Note 14, Contingencies and Commitments, in the 2013 Form 10-K). The receipt of insurance claim payments partly offset these costs for the six months ended January 31, 2013.
	Environmental matters: As discussed in Note 5, Contingencies and Commitments, in the six months ended January 31, 2014, the Company increased its previously established environmental reserve related to a matter in Pinellas Park, Florida.
	The following table summarizes the activity related to restructuring liabilities recorded for the Company’s structural cost improvement initiative which began in fiscal year 2012:
		Severance			Other			Total
	Original charge	$	61,852		$	3,448		$	65,300
	Utilized	(27,365		)	(2,798		)	(30,163		)
	Translation	(123		)	(47		)	(170		)
	Balance at Jul 31, 2012	$	34,364		$	603		$	34,967
	Additions	21,637			2,840			24,477
	Utilized	(29,574		)	(1,936		)	(31,510		)
	Reversal of excess reserves	(500		)	(57		)	(557		)
	Translation	313			23			336
	Balance at Jul 31, 2013	$	26,240		$	1,473		$	27,713
	Additions	10,462			2,137			12,599
	Utilized	(12,787		)	(1,592		)	(14,379		)
	Reversal of excess reserves	(506		)	(118		)	(624		)
	Translation	306			36			342
	Balance at Jan 31, 2014	$	23,715		$	1,936		$	25,651
	Excluded from the table above are restructuring liabilities relating to restructuring plans initiated in fiscal year 2010. At January 31, 2014, the balance of these liabilities was $216.

INCOME_TAXES

INCOME TAXES	6 Months Ended
	Jan. 31, 2014
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
	INCOME TAXES
	The Company’s effective tax rates on continuing operations for the six months ended January 31, 2014 and January 31, 2013 were 22.8% and 18.1%, respectively. For the six months ended January 31, 2014, the effective tax rate varied from the U.S. federal statutory rate primarily due to the benefits of foreign operations. For the six months ended January 31, 2013, the effective tax rate varied from the U.S. federal statutory rate primarily due to the benefits of foreign operations and a net tax benefit of $7,757 primarily from the resolution of a U.S. tax audit partly offset by the establishment of deferred tax liabilities for the repatriation of foreign earnings.
	During the six months ended January 31, 2013, the Company reached a final agreement with the Internal Revenue Service (“IRS”) resolving the outstanding tax positions for fiscal years ended 2006 through 2008. As a result, the Company reversed $10,193 of previously recorded liabilities related to tax and penalties, as well as $6,704 related to interest ($4,268 net of income tax cost) that were accrued but not assessed as part of the IRS agreement.
	At January 31, 2014 and July 31, 2013, the Company had gross unrecognized income tax benefits of $211,463 and $203,376, respectively. During the six months ended January 31, 2014, the amount of gross unrecognized tax benefits increased by $8,087, primarily due to tax positions taken during the current period and the impact of foreign currency translation partially offset by the expiration of various foreign statutes of limitation. As of January 31, 2014, the amount of net unrecognized income tax benefits that, if recognized, would impact the effective tax rate was $163,188.
	At January 31, 2014 and July 31, 2013, the Company had liabilities of $20,767 and $18,622, respectively, for potential payment of interest and penalties.
	Due to the potential resolution of tax examinations and the expiration of various statutes of limitation, the Company believes that it is reasonably possible that the gross amount of unrecognized tax benefits may decrease within the next twelve months by a range of zero to $66,183.
	Subsequent to the balance sheet date, the Company received official notification of the resolution of a tax audit in the United Kingdom related to fiscal year 2010. This will result in the recognition of previously unrecognized income tax benefits of approximately $8,000 and a reversal of interest of approximately $1,000 in the Company’s third fiscal quarter ending April 30, 2014.

COMPONENTS_OF_NET_PERIODIC_PEN

COMPONENTS OF NET PERIODIC PENSION COST	6 Months Ended
	Jan. 31, 2014
Compensation and Retirement Disclosure [Abstract]	'
COMPONENTS OF NET PERIODIC PENSION COST	'
	COMPONENTS OF NET PERIODIC PENSION COST
	Net periodic pension benefit cost for the Company’s defined benefit pension plans includes the following components:
		Three Months Ended
		U.S. Plans						Foreign Plans						Total
		Jan 31, 2014			Jan 31, 2013			Jan 31, 2014			Jan 31, 2013			Jan 31, 2014			Jan 31, 2013
	Service cost	$	2,170		$	2,647		$	997		$	1,161		$	3,167		$	3,808
	Interest cost	3,027			2,618			4,321			4,048			7,348			6,666
	Expected return on plan assets	(2,324		)	(2,384		)	(3,542		)	(4,118		)	(5,866		)	(6,502		)
	Amortization of prior service cost/(credit)	395			393			(10		)	(15		)	385			378
	Amortization of actuarial loss	1,345			2,411			1,425			1,412			2,770			3,823
	Loss due to curtailments and settlements	—			17			—			—			—			17
	Net periodic benefit cost	$	4,613		$	5,702		$	3,191		$	2,488		$	7,804		$	8,190
		Six Months Ended
		U.S. Plans						Foreign Plans						Total
		Jan 31, 2014			Jan 31, 2013			Jan 31, 2014			Jan 31, 2013			Jan 31, 2014			Jan 31, 2013
	Service cost	$	4,340		$	5,295		$	1,993		$	2,350		$	6,333		$	7,645
	Interest cost	6,055			5,235			8,525			8,066			14,580			13,301
	Expected return on plan assets	(4,649		)	(4,767		)	(6,980		)	(8,221		)	(11,629		)	(12,988		)
	Amortization of prior service cost/(credit)	790			786			(21		)	(32		)	769			754
	Amortization of actuarial loss	2,689			4,822			2,811			2,812			5,500			7,634
	Loss due to curtailments and settlements	—			33			—			—			—			33
	Net periodic benefit cost	$	9,225		$	11,404		$	6,328		$	4,975		$	15,553		$	16,379

STOCKBASED_PAYMENT

STOCK-BASED PAYMENT	6 Months Ended
	Jan. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
STOCK-BASED PAYMENT	'
	STOCK–BASED PAYMENT
	The Company currently has four stock-based employee and director compensation award types (Restricted Stock Unit, Stock Option Plans, Management Stock Purchase Plan (“MSPP”), and Employee Stock Purchase Plan (“ESPP”)), which are more fully described in Note 15, Common Stock, to the consolidated financial statements included in the 2013 Form 10-K.
	The detailed components of stock-based compensation expense recorded in the condensed consolidated statements of earnings for the three and six months ended January 31, 2014 and January 31, 2013 are reflected in the table below:
		Three Months Ended				Six Months Ended
		Jan 31, 2014		Jan 31, 2013		Jan 31, 2014		Jan 31, 2013
	Restricted stock units	$	6,254	$	4,609	$	10,447	$	7,917
	Stock options	1,965		1,544		3,486		2,678
	MSPP	972		937		1,164		1,787
	ESPP	273		302		498		690
	Total	$	9,464	$	7,392	$	15,595	$	13,072

EARNINGS_PER_SHARE

EARNINGS PER SHARE	6 Months Ended
	Jan. 31, 2014
Earnings Per Share [Abstract]	'
EARNINGS PER SHARE	'
	EARNINGS PER SHARE
	The condensed consolidated statements of earnings present basic and diluted earnings per share. Basic earnings per share is determined by dividing income available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share considers the potential effect of dilution on basic earnings per share assuming potentially dilutive shares that meet certain criteria, such as those issuable upon exercise of stock options, were outstanding. The treasury stock method reduces the dilutive effect of potentially dilutive securities as it assumes that any cash proceeds (from the issuance of potentially dilutive securities) are used to buy back shares at the average share price during the period. Employee stock options and restricted stock units aggregating 506 and 1,254 shares were not included in the computation of diluted shares for the three months ended January 31, 2014 and January 31, 2013, respectively, because their effect would have been antidilutive. For the six months ended January 31, 2014 and January 31, 2013, 921 and 1,175 antidilutive shares, respectively, were excluded. The following is a reconciliation between basic shares outstanding and diluted shares outstanding:
		Three Months Ended		Six Months Ended
		Jan 31, 2014	Jan 31, 2013	Jan 31, 2014	Jan 31, 2013
	Basic shares outstanding	110,720	112,420	111,263	113,398
	Effect of stock plans	1,260	1,389	1,269	1,386
	Diluted shares outstanding	111,980	113,809	112,532	114,784

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	6 Months Ended
	Jan. 31, 2014
Fair Value Disclosures [Abstract]	'
FAIR VALUE MEASUREMENTS	'
	FAIR VALUE MEASUREMENTS
	The Company records certain of its financial assets and liabilities at fair value, which is the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date.
	The current authoritative guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). Authoritative guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:
	•	Level 1: Use of observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.
	•	Level 2: Use of inputs other than quoted prices included in Level 1, which are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.
	•	Level 3: Use of inputs that are unobservable.
	The following table presents, for each of these hierarchy levels, the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of January 31, 2014:
		Fair Value Measurements
		As of
		Jan 31, 2014		Level 1		Level 2		Level 3
	Financial assets carried at fair value
	Money market funds	$	2,469	$	2,469	$	—	$	—
	Available-for-sale securities:
	Equity securities	203		203		—		—
	Debt securities:
	Corporate	30,191		—		30,191		—
	U.S. Treasury	10,793		—		10,793		—
	Federal agency	18,574		—		18,574		—
	Mortgage-backed	8,171		—		8,171		—
	Commercial paper	700		—		700		—
	Trading securities	216		216		—		—
	Derivative financial instruments:
	Foreign exchange forward contracts	4,512		—		4,512		—
	Financial liabilities carried at fair value
	Derivative financial instruments:
	Foreign exchange forward contracts	1,683		—		1,683		—
	The following table presents, for each of these hierarchy levels, the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of July 31, 2013:
		Fair Value Measurements
		As of
		Jul 31, 2013		Level 1		Level 2		Level 3
	Financial assets carried at fair value
	Money market funds	$	6,404	$	6,404	$	—	$	—
	Available-for-sale securities:
	Equity securities	176		176		—		—
	Debt securities:
	Corporate	32,393		—		32,393		—
	U.S. Treasury	11,543		—		11,543		—
	Federal agency	20,642		—		20,642		—
	Mortgage-backed	5,990		—		5,990		—
	Trading securities	190		190		—		—
	Derivative financial instruments:
	Foreign exchange forward contracts	301		—		301		—
	Financial liabilities carried at fair value
	Derivative financial instruments:
	Foreign exchange forward contracts	3,066		—		3,066		—
	The Company’s money market funds and equity securities are valued using quoted market prices and, as such, are classified within Level 1 of the fair value hierarchy.
	The fair value of the Company’s investments in debt securities are valued utilizing third party pricing services and verified by management. The pricing services use inputs to determine fair value which are derived from observable market sources including reportable trades, benchmark curves, credit spreads, broker/dealer quotes, bids, offers, and other industry and economic events. These investments are included in Level 2 of the fair value hierarchy.
	The fair values of the Company’s foreign currency forward contracts are valued using pricing models, with all significant inputs derived from or corroborated by observable market data such as yield curves, currency spot and forward rates, and currency volatilities. These investments are included in Level 2 of the fair value hierarchy.

INVESTMENT_SECURITIES

INVESTMENT SECURITIES	6 Months Ended
	Jan. 31, 2014
Investments, Debt and Equity Securities [Abstract]	'
INVESTMENT SECURITIES	'
	INVESTMENT SECURITIES
	The following is a summary of the Company’s available-for-sale investment securities by category which are classified within other non-current assets in the Company’s condensed consolidated balance sheets. Contractual maturity dates of debt securities held by the benefits protection trusts at January 31, 2014 range from 2014 to 2046.
		Cost/		Fair Value			Gross		Gross			Net Unrealized
		Amortized					Unrealized		Unrealized			Holding
		Cost Basis					Holding		Holding			Gains/(Losses)
							Gains		Losses
	January 31, 2014
	Equity securities	$	197	$	203		$	6	$	—		$	6
	Debt securities:
	Corporate	29,452		30,191			1,168		(429		)	739
	U.S. Treasury	10,741		10,793			206		(154		)	52
	Federal agency	17,978		18,574			1,002		(406		)	596
	Mortgage-backed	7,997		8,171			189		(15		)	174
	Commercial paper	699		700			1		—			1
		$	67,064	$	68,632		$	2,572	$	(1,004	)	$	1,568
	July 31, 2013
	Equity securities	$	176	$	176		$	—	$	—		$	—
	Debt securities:
	Corporate	31,546		32,393			1,274		(427		)	847
	U.S. Treasury	11,339		11,543			294		(90		)	204
	Federal agency	19,810		20,642			1,131		(299		)	832
	Mortgage-backed	5,752		5,990			238		—			238
		$	68,623	$	70,744		$	2,937	$	(816	)	$	2,121
	The following table shows the gross unrealized losses and fair value of the Company’s available-for-sale investments with unrealized losses aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:
		Less than 12 months					12 months or greater					Total
		Fair		Gross			Fair		Gross			Fair		Gross
		Value		Unrealized			Value		Unrealized			Value		Unrealized
				Holding					Holding					Holding
				Losses					Losses					Losses
	January 31, 2014
	Debt securities:
	Corporate	$	9,685	$	(429	)	$	—	$	—		$	9,685	$	(429	)
	U.S. Treasury	4,328		(154		)	—		—			4,328		(154		)
	Federal agency	3,785		(406		)	—		—			3,785		(406		)
	Mortgage-backed	2,932		(15		)	—		—			2,932		(15		)
		$	20,730	$	(1,004	)	$	—	$	—		$	20,730	$	(1,004	)
		Less than 12 months					12 months or greater					Total
		Fair		Gross			Fair		Gross			Fair		Gross
		Value		Unrealized			Value		Unrealized			Value		Unrealized
				Holding					Holding					Holding
				Losses					Losses					Losses
	July 31, 2013
	Debt securities:
	Corporate	10,990		(427		)	—		—			10,990		(427		)
	U.S. Treasury	3,778		(90		)	—		—			3,778		(90		)
	Federal agency	3,701		(299		)	—		—			3,701		(299		)
		$	18,469	$	(816	)	$	—	$	—		$	18,469	$	(816	)
	The following table shows the proceeds and gross gains and losses from the sale of available-for-sale investments for the three and six months ended January 31, 2014 and January 31, 2013:
		Three Months Ended					Six Months Ended
		Jan 31, 2014		Jan 31, 2013			Jan 31, 2014		Jan 31, 2013
	Proceeds from sales	$	2,558	$	6,689		$	3,058	$	12,286
	Realized gross gains on sales	84		160			84		352
	Realized gross losses on sales	99		3			100		5
	The following is a summary of the Company’s trading securities by category which are classified within other non-current assets in the Company’s condensed consolidated balance sheets.
		Jan 31, 2014		Jul 31, 2013
	Equity securities	$	216	$	190
	Total trading securities	$	216	$	190
	The following table shows the net gains and losses recognized on trading securities for the three and six months ended January 31, 2014 and January 31, 2013:
		Three Months Ended					Six Months Ended
		Jan 31, 2014		Jan 31, 2013			Jan 31, 2014		Jan 31, 2013
	Gains, net recognized for securities held	$	7	$	—		$	23	$	—
	Gains, net recognized for securities sold	—		—			—		—
	Total gains, net recognized	$	7	$	—		$	23	$	—

DERIVATIVE_INSTRUMENTS_AND_HED

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	6 Months Ended
	Jan. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	'
	DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
	The Company manages certain financial exposures through a risk management program that includes the use of foreign exchange derivative financial instruments. Derivatives are executed with counterparties with a minimum credit rating of “A” by Standard & Poors and “A2” by Moody’s Investor Services, in accordance with the Company’s policies. The Company does not utilize derivative instruments for trading or speculative purposes. As of January 31, 2014, the Company had foreign currency forward contracts outstanding with notional amounts aggregating $477,156, whose fair values were a net asset of $2,829.
	Foreign Exchange Related:
	a. Derivatives Not Designated as Hedging Instruments
	The risk management objective of holding foreign exchange derivatives is to mitigate volatility to earnings and cash flows due to changes in foreign exchange rates. The Company and its subsidiaries conduct transactions in currencies other than their functional currencies. These transactions include non-functional intercompany and external sales as well as intercompany and external purchases. The Company uses foreign exchange forward contracts, matching the notional amounts and durations of the receivables and payables resulting from the aforementioned underlying foreign currency transactions, to mitigate the exposure to earnings and cash flows caused by the changes in fair value of these receivables and payables from fluctuating foreign exchange rates. The notional amount of foreign currency forward contracts not designated as hedging instruments entered into during the three and six months ended January 31, 2014 was $607,273 and $1,181,442, respectively. The notional amount of foreign currency forward contracts outstanding that were not designated as hedging instruments as of January 31, 2014 was $369,219.
	b. Cash Flow Hedges
	The Company uses foreign exchange forward contracts for cash flow hedging on its future transactional exposure to the Euro due to changes in market rates to exchange Euros for British Pounds. The hedges cover a British subsidiary (British Pound functional) with Euro revenues and a Swiss subsidiary (Euro functional) with British Pound expenses. The probability of the occurrence of these transactions is high and the Company’s assessment is based on observable facts including the frequency and amounts of similar past transactions. The objective of the cash flow hedges is to lock the British Pound equivalent amount of Euro sales for the British subsidiary and the Euro equivalent amount of British Pound expenses for the Swiss subsidiary at the agreed upon exchange rates in the foreign exchange forward contracts. The notional amount of foreign currency forward contracts designated as hedging instruments entered into during the three and six months ended January 31, 2014 was $54,767. The notional amount of foreign currency forward contracts outstanding designated as hedging instruments as of January 31, 2014 was $107,937 and covers certain monthly transactional exposures through February 2015.
	c. Net Investment Hedges
	The risk management objective of designating the Company’s foreign currency loan as a hedge of a portion of its net investment in a wholly owned Japanese subsidiary is to mitigate the change in the fair value of the Company’s net investment due to changes in foreign exchange rates. The Company uses a JPY loan outstanding to hedge its equity of the same amount in the Japanese wholly owned subsidiary. The hedge of net investment consists of a JPY 9 billion loan.
	The fair values of the Company’s derivative financial instruments included in the condensed consolidated balance sheets are presented as follows:
		Asset Derivatives						Liability Derivatives
	January 31, 2014	Balance Sheet Location		Fair Value				Balance Sheet Location		Fair Value
	Derivatives designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	3,567			Other current liabilities		$	4
	Derivatives not designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	945			Other current liabilities		$	1,679
	Total derivatives			$	4,512					$	1,683
	Nonderivative instruments designated as hedging instruments
	Net investment hedge							Long-term debt, net of current portion		$	87,624
		Asset Derivatives						Liability Derivatives
	July 31, 2013	Balance Sheet Location		Fair Value				Balance Sheet Location		Fair Value
	Derivatives designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	—			Other current liabilities		$	1,941
	Derivatives not designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	301			Other current liabilities		$	1,125
	Total derivatives			$	301					$	3,066
	Nonderivative instruments designated as hedging instruments
	Net investment hedge							Long-term debt, net of current portion		$	91,800
	The amounts of the gains and losses related to the Company’s derivative financial instruments designated as hedging instruments for the three and six months ended January 31, 2014 and January 31, 2013 are presented as follows:
		Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion)								Location of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion)		Amount of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion) (a)
		Three Months Ended										Three Months Ended
		Jan 31, 2014				Jan 31, 2013						Jan 31, 2014			Jan 31, 2013
	Derivatives in cash flow hedging relationships
	Foreign exchange forward contracts	$	3,489			$	(1,825	)		Net sales		$	113		$	(296	)
										Cost of sales		(46		)	(170		)
	Total derivatives	$	3,489			$	(1,825	)				$	67		$	(466	)
		Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion)								Location of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion)		Amount of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion) (a)
		Six Months Ended										Six Months Ended
		31-Jan-14				31-Jan-13						31-Jan-14			31-Jan-13
	Derivatives in cash flow hedging relationships
	Foreign exchange forward contracts	$	5,310			$	(3,777	)		Net sales		$	112		$	(387	)
										Cost of sales		(866		)	(170		)
	Total derivatives	$	5,310			$	(3,777	)				$	(754	)	$	(557	)
	(a)	There were no gains or losses recognized in earnings related to the ineffective portion of the hedging relationship or related to the amount excluded from the assessment of hedge effectiveness for the three and six months ended January 31, 2014 and January 31, 2013.
	The amounts of the gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments for the three and six months ended January 31, 2014 and January 31, 2013 are presented as follows:
				Amount of Gain or (Loss) Recognized in
				Earnings on Derivatives
				Three Months Ended								Six Months Ended
		Location of Gain or (Loss) Recognized in Earnings on Derivatives		Jan 31, 2014				Jan 31, 2013				Jan 31, 2014			Jan 31, 2013
	Derivatives not designated as hedging relationships
	Foreign exchange forward contracts	Selling, general and administrative expenses		$	(2,792	)		$	(7,388	)		$	(2,343	)	$	(9,826	)
	The amounts of the gains and losses related to the Company’s nonderivative financial instruments designated as hedging instruments for the three and six months ended January 31, 2014 and January 31, 2013 are presented as follows:
		Amount of Gain or (Loss)								Location of Gain or		Amount of Gain or (Loss) Reclassified from
		Recognized in OCI on Derivatives								(Loss) Reclassified		Accumulated OCI into Earnings
		(Effective Portion)								from Accumulated		(Effective Portion) (b)
										OCI into Earnings
										(Effective Portion)
		Three Months Ended										Three Months Ended
		Jan 31, 2014				Jan 31, 2013						Jan 31, 2014			Jan 31, 2013
	Nonderivatives designated as hedging relationships
	Net investment hedge	$	(3,735	)		$	9,100			N/A		$	—		$	—
		Amount of Gain or (Loss)								Location of Gain or		Amount of Gain or (Loss) Reclassified from
		Recognized in OCI on Derivatives								(Loss) Reclassified		Accumulated OCI into Earnings
(Effective Portion)							from Accumulated	(Effective Portion) (b)
							OCI into Earnings
							(Effective Portion)
	Six Months Ended										Six Months Ended
	Jan 31, 2014				Jan 31, 2013						Jan 31, 2014			Jan 31, 2013
Nonderivatives designated as hedging relationships
Net investment hedge	$	(4,176	)		$	10,437			N/A		$	—		$	—
(b)	There were no gains or losses recognized in earnings related to the ineffective portion of the hedging relationship or related to the amount excluded from the assessment of hedge effectiveness for the three and six months ended January 31, 2014 and January 31, 2013.

ACCUMULATED_OTHER_COMPREHENSIV

ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS)	6 Months Ended
	Jan. 31, 2014
Accumulated Other Comprehensive Income/(Loss) [Abstract]	'
ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS)	'
	ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS)
	Changes in accumulated other comprehensive income by component are presented below:
		Foreign Currency Translation			Defined Benefit Pension Plan			Unrealized investment gains/(losses)			Unrealized gains/(losses) on derivatives			Accumulated other comprehensive income/(loss)
	Balance at July 31, 2013	$	84,598		$	(125,211	)	$	2,123		$	(2,302	)	$	(40,792	)
	Other comprehensive income/(loss) before reclassifications	21,289			—			(450		)	4,817			25,656
	Amounts reclassified from accumulated other comprehensive income (loss)	—			4,330			76			764			5,170
	Foreign exchange adjustments and other	—			(4,995		)	—			—			(4,995		)
	Balance at January 31, 2014	$	105,887		$	(125,876	)	$	1,749		$	3,279		$	(14,961	)
	Reclassifications out of accumulated other comprehensive income are presented below:
		Three Months Ended			Six Months Ended			Affected line item in the Condensed Consolidated Statement of Earnings
		31-Jan-14			31-Jan-14
	Defined Benefit Pension Plan
	Amortization of prior service cost	$	(385	)	$	(769	)	Note (a)
	Recognized actuarial gain/(loss)	(2,770		)	(5,500		)	Note (a)
	Total before tax	(3,155		)	(6,269		)
	Tax benefit	974			1,939
	Net of tax	$	(2,181	)	$	(4,330	)
	Unrealized investment gains/(losses)
	Realized investment gain/(losses)	$	(62	)	$	(119	)	Selling, general and administrative
	Tax (expense)/benefit	23			43
	Net of tax	$	(39	)	$	(76	)
	Unrealized gains/(losses) on derivatives
	Foreign exchange forward contracts	$	113		$	112		Sales
	Foreign exchange forward contracts	(46		)	(866		)	Cost of sales
	Total before tax	67			(754		)
	Tax benefit	(24		)	(10		)
	Net of tax	$	43		$	(764	)
	(a)	These accumulated other comprehensive income components are included in the computation of net periodic pension cost (see Note 8, Components of Net Periodic Pension Cost, for additional details).

SEGMENT_INFORMATION

SEGMENT INFORMATION	6 Months Ended
	Jan. 31, 2014
Segment Reporting [Abstract]	'
SEGMENT INFORMATION	'
	SEGMENT INFORMATION
	The Company’s reportable segments, which are also its operating segments, consist of the Company’s Life Sciences and Industrial businesses.
	The following table presents sales and segment profit from continuing operations by business segment reconciled to earnings from continuing operations before income taxes for the three and six months ended January 31, 2014 and January 31, 2013.
		Three Months Ended				Six Months Ended
		Jan 31, 2014		Jan 31, 2013		Jan 31, 2014		Jan 31, 2013
	SALES:
	Life Sciences	$	353,230	$	329,182	$	672,176	$	629,133
	Industrial	323,739		333,273		634,572		660,922
	Total	$	676,969	$	662,455	$	1,306,748	$	1,290,055
	SEGMENT PROFIT:
	Life Sciences	$	90,856	$	82,477	$	163,901	$	152,319
	Industrial	46,891		48,104		97,373		100,870
	Total segment profit	137,747		130,581		261,274		253,189
	Corporate Services Group	14,766		18,026		30,730		32,091
	ROTC	9,170		4,399		18,368		8,673
	Interest expense, net	5,195		6,017		11,172		5,449
	Earnings from continuing operations before income taxes	$	108,616	$	102,139	$	201,004	$	206,976

DISCONTINUED_OPERATIONS

DISCONTINUED OPERATIONS	6 Months Ended
	Jan. 31, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
DISCONTINUED OPERATIONS	'
	DISCONTINUED OPERATIONS
	On April 28, 2012, the Company entered into an asset purchase agreement (“APA”) to sell certain assets of its blood collection, filtration and processing product line (the “Product Line”) to Haemonetics Corporation (“Haemonetics”) for approximately $550,000. The transaction involved the transfer of manufacturing facilities and equipment in Covina, California; Tijuana, Mexico; Ascoli, Italy and a portion of the Company’s operations in Fajardo, Puerto Rico. In addition to the manufacturing facilities and related equipment, the Company transferred Product Line related inventory and intangible assets. Haemonetics also assumed certain employee-related liabilities. The sale closed on August 1, 2012, and approximately 1,400 employees transitioned to Haemonetics at that time.
	Separate from these manufacturing facilities, the Company also agreed to transfer related blood media manufacturing capabilities and assets to Haemonetics. The transfer of the related media lines is expected to be completed by calendar year 2016. Until that time, the Company is providing these media products to Haemonetics under a supply agreement. Under the terms of the APA, approximately $535,000 was paid upon closing, with the balance of the purchase price payable upon the Company’s delivery of the aforementioned blood media manufacturing capability and related assets.
	The Product Line, which was a component of the Company’s Life Sciences segment, met the criteria for discontinued operations and held for sale presentation during the third quarter of fiscal year 2012 and has been reported as a discontinued operation in the Company’s condensed consolidated financial statements. The Company did not allocate any portion of the Company’s interest expense to discontinued operations.
	The key components of discontinued operations for the three and six months ended January 31, 2013 were as follows:
		Three Months Ended			Six Months Ended
		Jan 31, 2013			Jan 31, 2013
	Net sales	$	5,496		$	8,523
	Earnings/(loss) from discontinued operations before income taxes	$	(5,663	)	$	394,321
	Provision/(benefit) for income taxes	(2,114		)	147,563
	Earnings/(loss) from discontinued operations, net of income taxes	$	(3,549	)	$	246,758
	Included in earnings from discontinued operations before income taxes above are a (loss)/gain on the sale of the Product Line of $(2,945) and $397,338, respectively, for the three and six months ended January 31, 2013.

SUBSEQUENT_EVENT

SUBSEQUENT EVENT	6 Months Ended
	Jan. 31, 2014
SUBSEQUENT EVENT [Abstract]	'
Business Combination Disclosure [Text Block]	'
	SUBSEQUENT EVENT
	On February 20, 2014 (the “Closing Date”), the Company acquired the Life Sciences business of ATMI, Inc (“ATMI LifeSciences”). ATMI LifeSciences is a technology leader in the field of single-use bioprocess equipment and consumables for the biopharmaceutical and biotechnology industries. The acquisition includes the ATMI LifeSciences portfolio of custom-engineered, flexible packaging solutions, single-use storage systems, mixers and bioreactors. On the Closing Date, the Company paid a cash purchase price of $185,000, subject to a post closing working capital adjustment.

BASIS_OF_PRESENTATION_Policies

BASIS OF PRESENTATION (Policies)	6 Months Ended
	Jan. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Fair Value of Financial Instruments, Policy	'
	The Company’s money market funds and equity securities are valued using quoted market prices and, as such, are classified within Level 1 of the fair value hierarchy.
	The fair value of the Company’s investments in debt securities are valued utilizing third party pricing services and verified by management. The pricing services use inputs to determine fair value which are derived from observable market sources including reportable trades, benchmark curves, credit spreads, broker/dealer quotes, bids, offers, and other industry and economic events. These investments are included in Level 2 of the fair value hierarchy.
	The fair values of the Company’s foreign currency forward contracts are valued using pricing models, with all significant inputs derived from or corroborated by observable market data such as yield curves, currency spot and forward rates, and currency volatilities. These investments are included in Level 2 of the fair value hierarchy.
Presentation and Use of Estimates	'
	The condensed consolidated financial information of Pall Corporation and its subsidiaries (hereinafter collectively called the “Company”) included herein is unaudited. Such information reflects all adjustments of a normal recurring nature, which are, in the opinion of Company management, necessary to present fairly the Company’s consolidated financial position, results of operations and cash flows as of the dates and for the periods presented herein. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended July 31, 2013 (“2013 Form 10-K”).

BALANCE_SHEET_DETAILS_Tables

BALANCE SHEET DETAILS (Tables)	6 Months Ended
	Jan. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Summary of Accounts Receivable	'
		Jan 31, 2014			Jul 31, 2013
	Accounts receivable:
	Billed	$	482,809		$	508,448
	Unbilled	67,548			72,787
	Total	550,357			581,235
	Less: Allowances for doubtful accounts	(13,602		)	(14,900		)
		$	536,755		$	566,335
	Unbilled receivables principally relate to revenues accrued for long-term contracts recorded under the percentage-of-completion method of accounting.
Major Classes of Inventory	'
		Jan 31, 2014			Jul 31, 2013
	Inventory:
	Raw materials and components	$	114,702		$	94,837
	Work-in-process	105,484			94,998
	Finished goods	174,679			191,212
		$	394,865		$	381,047
Schedule of Property, Plant And Equipment	'
		Jan 31, 2014			July 31, 2013
	Property, plant and equipment:
	Property, plant and equipment	$	1,719,826		$	1,650,274
	Less: Accumulated depreciation and amortization	(930,484		)	(875,326		)
		$	789,342		$	774,948

GOODWILL_AND_INTANGIBLE_ASSETS1

GOODWILL AND INTANGIBLE ASSETS (Tables)	6 Months Ended
	Jan. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill, allocated by reportable segment	'
	The following table presents goodwill, allocated by reportable segment.
		Jan 31, 2014		Jul 31, 2013
	Life Sciences	$	186,098	$	180,896
	Industrial	161,982		161,596
		$	348,080	$	342,492
Schedule of Intangible Assets	'
		Jan 31, 2014
		Gross		Accumulated		Net
				Amortization
	Patents and unpatented technology	$	112,559	$	62,044	$	50,515
	Customer-related intangibles	106,290		27,354		78,936
	Trademarks	13,353		6,573		6,780
	Other	3,638		2,484		1,154
		$	235,840	$	98,455	$	137,385
		Jul 31, 2013
		Gross		Accumulated		Net
				Amortization
	Patents and unpatented technology	$	123,707	$	69,992	$	53,715
	Customer-related intangibles	97,016		22,425		74,591
	Trademarks	13,291		6,166		7,125
	Other	4,425		2,613		1,812
		$	238,439	$	101,196	$	137,243

TREASURY_STOCK_Tables

TREASURY STOCK (Tables)	6 Months Ended
	Jan. 31, 2014
Stockholders' Equity Note [Abstract]	'
Schedule of Treasury Stock by Class	'
	The following table highlights the share repurchase authorizations in effect during fiscal year 2014:
		Date of Authorization
		26-Sep-11			17-Jan-13			Total
	Amount available for repurchases as of July 31, 2013	$	81,873		$	250,000		$	331,873
	New authorizations	—			—			—
	Utilized	(81,873		)	(168,127		)	(250,000		)
	Amount available for repurchases as of January 31, 2014	$	—		$	81,873		$	81,873

RESTRUCTURING_AND_OTHER_CHARGE1

RESTRUCTURING AND OTHER CHARGES, NET (Tables)	6 Months Ended
	Jan. 31, 2014
Restructuring and Related Activities [Abstract]	'
Summary of Restructuring and Other Charges	'
	The following tables summarize the restructuring and other charges (“ROTC”) recorded in the three and six months ended January 31, 2014 and January 31, 2013:
		Three Months Ended Jan 31, 2014									Six Months Ended Jan 31, 2014
		Restructuring			Other			Total			Restructuring			Other			Total
		-1			(Gains)/						-1			(Gains)/
					Charges									Charges
					-2									-2
	Severance benefits and other employment contract obligations	$	7,347		$	(844	)	$	6,503		$	10,462		$	(402	)	$	10,060
	Professional fees and other costs, net of receipt of insurance claim payments	894			2,053			2,947			2,137			2,195			4,332
	(Gain)/loss on sale and impairment of assets, net	—			—			—			—			160			160
	Environmental matters	—			—			—			—			4,440			4,440
	Reversal of excess restructuring reserves	(280		)	—			(280		)	(624		)	—			(624		)
		$	7,961		$	1,209		$	9,170		$	11,975		$	6,393		$	18,368
	Cash	$	7,961		$	1,209		$	9,170		$	11,975		$	6,233		$	18,208
	Non-cash	—			—			—			—			160			160
		$	7,961		$	1,209		$	9,170		$	11,975		$	6,393		$	18,368
		Three Months Ended Jan 31, 2013									Six Months Ended Jan 31, 2013
		Restructuring			Other			Total			Restructuring			Other			Total
		-1			(Gains)/						-1			(Gains)/
					Charges									Charges
					-2									-2
	Severance benefits and other employment contract obligations	$	1,916		$	1,451		$	3,367		$	5,195		$	1,451		$	6,646
	Professional fees and other costs, net of receipt of insurance claim payments	345			887			1,232			788			1,586			2,374
	(Gain)/loss on sale and impairment of assets, net	(49		)	—			(49		)	(6		)	—			(6		)
	Reversal of excess restructuring reserves	(151		)	—			(151		)	(341		)	—			(341		)
		$	2,061		$	2,338		$	4,399		$	5,636		$	3,037		$	8,673
	Cash	$	1,705		$	1,825		$	3,530		$	5,237		$	2,524		$	7,761
	Non-cash	356			513			869			399			513			912
		$	2,061		$	2,338		$	4,399		$	5,636		$	3,037		$	8,673
	(1) Restructuring:
	In fiscal year 2012, the Company announced a multi-year strategic cost reduction initiative (“structural cost improvement initiative”). This initiative impacts both segments as well as the Corporate Services Group. The goal of this initiative is to properly position the Company’s cost structure globally to perform in the current economic environment without adversely impacting its growth or innovation potential.
	Key components of the structural cost improvement initiative include:
	•	the strategic alignment of manufacturing, sales and R&D facilities to cost-effectively deliver high-quality products and superior service to the Company’s customers worldwide,
	•	creation of regional shared financial services centers for the handling of accounting transaction processing and other accounting functions,
	•	reorganization of sales functions, to more cost-efficiently deliver superior service to the Company’s customers globally, and
	•	reductions in headcount across all functional areas, enabled by efficiencies gained through the Company’s ERP systems, as well as in order to align to economic conditions.
	Restructuring charges recorded in the three and six months ended January 31, 2014 and January 31, 2013 primarily reflect the expenses incurred in connection with the Company’s structural cost improvement initiative as discussed above.
	(2) Other (Gains)/Charges:
	Severance benefits and other employment contract obligations: In the three months ended January 31, 2013, the Company recorded charges related to certain employment contract obligations.
	Professional fees and other: In the three months ended January 31, 2014, the Company recorded acquisition related legal and other professional fees. In the three and six months ended January 31, 2013, the Company recorded settlement related costs as well as legal and other professional fees, related to the Federal Securities Class Actions, Shareholder Derivative Lawsuits and Other Proceedings (see Note 14, Contingencies and Commitments, in the 2013 Form 10-K). The receipt of insurance claim payments partly offset these costs for the six months ended January 31, 2013.
	Environmental matters: As discussed in Note 5, Contingencies and Commitments, in the six months ended January 31, 2014, the Company increased its previously established environmental reserve related to a matter in Pinellas Park, Florida.
Schedule of Summarized Activity Relating to Restructuring	'
	he following table summarizes the activity related to restructuring liabilities recorded for the Company’s structural cost improvement initiative which began in fiscal year 2012:
		Severance			Other			Total
	Original charge	$	61,852		$	3,448		$	65,300
	Utilized	(27,365		)	(2,798		)	(30,163		)
	Translation	(123		)	(47		)	(170		)
	Balance at Jul 31, 2012	$	34,364		$	603		$	34,967
	Additions	21,637			2,840			24,477
	Utilized	(29,574		)	(1,936		)	(31,510		)
	Reversal of excess reserves	(500		)	(57		)	(557		)
	Translation	313			23			336
	Balance at Jul 31, 2013	$	26,240		$	1,473		$	27,713
	Additions	10,462			2,137			12,599
	Utilized	(12,787		)	(1,592		)	(14,379		)
	Reversal of excess reserves	(506		)	(118		)	(624		)
	Translation	306			36			342
	Balance at Jan 31, 2014	$	23,715		$	1,936		$	25,651
	Excluded from the table above are restructuring liabilities relating to restructuring plans initiated in fiscal year 2010. At January 31, 2014, the balance of these liabilities was $216.

COMPONENTS_OF_NET_PERIODIC_PEN1

COMPONENTS OF NET PERIODIC PENSION COST (Tables)	6 Months Ended
	Jan. 31, 2014
Compensation and Retirement Disclosure [Abstract]	'
Net periodic benefit cost for the Company's defined benefit pension plans	'
	Net periodic pension benefit cost for the Company’s defined benefit pension plans includes the following components:
		Three Months Ended
		U.S. Plans						Foreign Plans						Total
		Jan 31, 2014			Jan 31, 2013			Jan 31, 2014			Jan 31, 2013			Jan 31, 2014			Jan 31, 2013
	Service cost	$	2,170		$	2,647		$	997		$	1,161		$	3,167		$	3,808
	Interest cost	3,027			2,618			4,321			4,048			7,348			6,666
	Expected return on plan assets	(2,324		)	(2,384		)	(3,542		)	(4,118		)	(5,866		)	(6,502		)
	Amortization of prior service cost/(credit)	395			393			(10		)	(15		)	385			378
	Amortization of actuarial loss	1,345			2,411			1,425			1,412			2,770			3,823
	Loss due to curtailments and settlements	—			17			—			—			—			17
	Net periodic benefit cost	$	4,613		$	5,702		$	3,191		$	2,488		$	7,804		$	8,190
		Six Months Ended
		U.S. Plans						Foreign Plans						Total
		Jan 31, 2014			Jan 31, 2013			Jan 31, 2014			Jan 31, 2013			Jan 31, 2014			Jan 31, 2013
	Service cost	$	4,340		$	5,295		$	1,993		$	2,350		$	6,333		$	7,645
	Interest cost	6,055			5,235			8,525			8,066			14,580			13,301
	Expected return on plan assets	(4,649		)	(4,767		)	(6,980		)	(8,221		)	(11,629		)	(12,988		)
	Amortization of prior service cost/(credit)	790			786			(21		)	(32		)	769			754
	Amortization of actuarial loss	2,689			4,822			2,811			2,812			5,500			7,634
	Loss due to curtailments and settlements	—			33			—			—			—			33
	Net periodic benefit cost	$	9,225		$	11,404		$	6,328		$	4,975		$	15,553		$	16,379

STOCKBASED_PAYMENT_Tables

STOCK-BASED PAYMENT (Tables)	6 Months Ended
	Jan. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Share Based Compensation Components of stock-based compensation expense	'
	The detailed components of stock-based compensation expense recorded in the condensed consolidated statements of earnings for the three and six months ended January 31, 2014 and January 31, 2013 are reflected in the table below:
		Three Months Ended				Six Months Ended
		Jan 31, 2014		Jan 31, 2013		Jan 31, 2014		Jan 31, 2013
	Restricted stock units	$	6,254	$	4,609	$	10,447	$	7,917
	Stock options	1,965		1,544		3,486		2,678
	MSPP	972		937		1,164		1,787
	ESPP	273		302		498		690
	Total	$	9,464	$	7,392	$	15,595	$	13,072

EARNINGS_PER_SHARE_Tables

EARNINGS PER SHARE (Tables)	6 Months Ended
	Jan. 31, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted	'
	The following is a reconciliation between basic shares outstanding and diluted shares outstanding:
		Three Months Ended		Six Months Ended
		Jan 31, 2014	Jan 31, 2013	Jan 31, 2014	Jan 31, 2013
	Basic shares outstanding	110,720	112,420	111,263	113,398
	Effect of stock plans	1,260	1,389	1,269	1,386
	Diluted shares outstanding	111,980	113,809	112,532	114,784

FAIR_VALUE_MEASUREMENTS_Tables

FAIR VALUE MEASUREMENTS (Tables)	6 Months Ended
	Jan. 31, 2014
Fair Value Disclosures [Abstract]	'
Schedule of financial assets and liabilities that are measured at fair value on a recurring basis	'
	The following table presents, for each of these hierarchy levels, the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of January 31, 2014:
		Fair Value Measurements
		As of
		Jan 31, 2014		Level 1		Level 2		Level 3
	Financial assets carried at fair value
	Money market funds	$	2,469	$	2,469	$	—	$	—
	Available-for-sale securities:
	Equity securities	203		203		—		—
	Debt securities:
	Corporate	30,191		—		30,191		—
	U.S. Treasury	10,793		—		10,793		—
	Federal agency	18,574		—		18,574		—
	Mortgage-backed	8,171		—		8,171		—
	Commercial paper	700		—		700		—
	Trading securities	216		216		—		—
	Derivative financial instruments:
	Foreign exchange forward contracts	4,512		—		4,512		—
	Financial liabilities carried at fair value
	Derivative financial instruments:
	Foreign exchange forward contracts	1,683		—		1,683		—
	The following table presents, for each of these hierarchy levels, the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of July 31, 2013:
		Fair Value Measurements
		As of
		Jul 31, 2013		Level 1		Level 2		Level 3
	Financial assets carried at fair value
	Money market funds	$	6,404	$	6,404	$	—	$	—
	Available-for-sale securities:
	Equity securities	176		176		—		—
	Debt securities:
	Corporate	32,393		—		32,393		—
	U.S. Treasury	11,543		—		11,543		—
	Federal agency	20,642		—		20,642		—
	Mortgage-backed	5,990		—		5,990		—
	Trading securities	190		190		—		—
	Derivative financial instruments:
	Foreign exchange forward contracts	301		—		301		—
	Financial liabilities carried at fair value
	Derivative financial instruments:
	Foreign exchange forward contracts	3,066		—		3,066		—

INVESTMENT_SECURITIES_Tables

INVESTMENT SECURITIES (Tables)	6 Months Ended
	Jan. 31, 2014
Investments, Debt and Equity Securities [Abstract]	'
Summary of the Company's available-for-sale investments by category	'
	The following is a summary of the Company’s available-for-sale investment securities by category which are classified within other non-current assets in the Company’s condensed consolidated balance sheets. Contractual maturity dates of debt securities held by the benefits protection trusts at January 31, 2014 range from 2014 to 2046.
		Cost/		Fair Value			Gross		Gross			Net Unrealized
		Amortized					Unrealized		Unrealized			Holding
		Cost Basis					Holding		Holding			Gains/(Losses)
							Gains		Losses
	January 31, 2014
	Equity securities	$	197	$	203		$	6	$	—		$	6
	Debt securities:
	Corporate	29,452		30,191			1,168		(429		)	739
	U.S. Treasury	10,741		10,793			206		(154		)	52
	Federal agency	17,978		18,574			1,002		(406		)	596
	Mortgage-backed	7,997		8,171			189		(15		)	174
	Commercial paper	699		700			1		—			1
		$	67,064	$	68,632		$	2,572	$	(1,004	)	$	1,568
	July 31, 2013
	Equity securities	$	176	$	176		$	—	$	—		$	—
	Debt securities:
	Corporate	31,546		32,393			1,274		(427		)	847
	U.S. Treasury	11,339		11,543			294		(90		)	204
	Federal agency	19,810		20,642			1,131		(299		)	832
	Mortgage-backed	5,752		5,990			238		—			238
		$	68,623	$	70,744		$	2,937	$	(816	)	$	2,121
Gross unrealized losses and fair value of Company's available-for-sale investments with unrealized losses aggregated by investment category and length of time	'
	The following table shows the gross unrealized losses and fair value of the Company’s available-for-sale investments with unrealized losses aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:
		Less than 12 months					12 months or greater					Total
		Fair		Gross			Fair		Gross			Fair		Gross
		Value		Unrealized			Value		Unrealized			Value		Unrealized
				Holding					Holding					Holding
				Losses					Losses					Losses
	January 31, 2014
	Debt securities:
	Corporate	$	9,685	$	(429	)	$	—	$	—		$	9,685	$	(429	)
	U.S. Treasury	4,328		(154		)	—		—			4,328		(154		)
	Federal agency	3,785		(406		)	—		—			3,785		(406		)
	Mortgage-backed	2,932		(15		)	—		—			2,932		(15		)
		$	20,730	$	(1,004	)	$	—	$	—		$	20,730	$	(1,004	)
		Less than 12 months					12 months or greater					Total
		Fair		Gross			Fair		Gross			Fair		Gross
		Value		Unrealized			Value		Unrealized			Value		Unrealized
				Holding					Holding					Holding
				Losses					Losses					Losses
	July 31, 2013
	Debt securities:
	Corporate	10,990		(427		)	—		—			10,990		(427		)
	U.S. Treasury	3,778		(90		)	—		—			3,778		(90		)
	Federal agency	3,701		(299		)	—		—			3,701		(299		)
		$	18,469	$	(816	)	$	—	$	—		$	18,469	$	(816	)
Proceeds and gross gains and losses from the sale of available-for-sale investments	'
	The following table shows the proceeds and gross gains and losses from the sale of available-for-sale investments for the three and six months ended January 31, 2014 and January 31, 2013:
		Three Months Ended					Six Months Ended
		Jan 31, 2014		Jan 31, 2013			Jan 31, 2014		Jan 31, 2013
	Proceeds from sales	$	2,558	$	6,689		$	3,058	$	12,286
	Realized gross gains on sales	84		160			84		352
	Realized gross losses on sales	99		3			100		5
Trading Securities [Table Text Block]	'
	The following is a summary of the Company’s trading securities by category which are classified within other non-current assets in the Company’s condensed consolidated balance sheets.
		Jan 31, 2014		Jul 31, 2013
	Equity securities	$	216	$	190
	Total trading securities	$	216	$	190
	The following table shows the net gains and losses recognized on trading securities for the three and six months ended January 31, 2014 and January 31, 2013:
		Three Months Ended					Six Months Ended
		Jan 31, 2014		Jan 31, 2013			Jan 31, 2014		Jan 31, 2013
	Gains, net recognized for securities held	$	7	$	—		$	23	$	—
	Gains, net recognized for securities sold	—		—			—		—
	Total gains, net recognized	$	7	$	—		$	23	$	—

DERIVATIVE_INSTRUMENTS_AND_HED1

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)	6 Months Ended
	Jan. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Fair values of the Company's derivative financial instruments included in the consolidated balance sheets	'
	The fair values of the Company’s derivative financial instruments included in the condensed consolidated balance sheets are presented as follows:
		Asset Derivatives						Liability Derivatives
	January 31, 2014	Balance Sheet Location		Fair Value				Balance Sheet Location		Fair Value
	Derivatives designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	3,567			Other current liabilities		$	4
	Derivatives not designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	945			Other current liabilities		$	1,679
	Total derivatives			$	4,512					$	1,683
	Nonderivative instruments designated as hedging instruments
	Net investment hedge							Long-term debt, net of current portion		$	87,624
		Asset Derivatives						Liability Derivatives
	July 31, 2013	Balance Sheet Location		Fair Value				Balance Sheet Location		Fair Value
	Derivatives designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	—			Other current liabilities		$	1,941
	Derivatives not designated as hedging instruments
	Foreign exchange forward contracts	Other current assets		$	301			Other current liabilities		$	1,125
	Total derivatives			$	301					$	3,066
	Nonderivative instruments designated as hedging instruments
	Net investment hedge							Long-term debt, net of current portion		$	91,800
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]	'
	The amounts of the gains and losses related to the Company’s derivative financial instruments designated as hedging instruments for the three and six months ended January 31, 2014 and January 31, 2013 are presented as follows:
		Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion)								Location of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion)		Amount of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion) (a)
		Three Months Ended										Three Months Ended
		Jan 31, 2014				Jan 31, 2013						Jan 31, 2014			Jan 31, 2013
	Derivatives in cash flow hedging relationships
	Foreign exchange forward contracts	$	3,489			$	(1,825	)		Net sales		$	113		$	(296	)
										Cost of sales		(46		)	(170		)
	Total derivatives	$	3,489			$	(1,825	)				$	67		$	(466	)
		Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion)								Location of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion)		Amount of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion) (a)
		Six Months Ended										Six Months Ended
		31-Jan-14				31-Jan-13						31-Jan-14			31-Jan-13
	Derivatives in cash flow hedging relationships
	Foreign exchange forward contracts	$	5,310			$	(3,777	)		Net sales		$	112		$	(387	)
										Cost of sales		(866		)	(170		)
	Total derivatives	$	5,310			$	(3,777	)				$	(754	)	$	(557	)
	(a)	There were no gains or losses recognized in earnings related to the ineffective portion of the hedging relationship or related to the amount excluded from the assessment of hedge effectiveness for the three and six months ended January 31, 2014 and January 31, 2013.
	The amounts of the gains and loss
Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location	'
	The amounts of the gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments for the three and six months ended January 31, 2014 and January 31, 2013 are presented as follows:
				Amount of Gain or (Loss) Recognized in
				Earnings on Derivatives
				Three Months Ended								Six Months Ended
		Location of Gain or (Loss) Recognized in Earnings on Derivatives		Jan 31, 2014				Jan 31, 2013				Jan 31, 2014			Jan 31, 2013
	Derivatives not designated as hedging relationships
	Foreign exchange forward contracts	Selling, general and administrative expenses		$	(2,792	)		$	(7,388	)		$	(2,343	)	$	(9,826	)
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)	'
	The amounts of the gains and losses related to the Company’s nonderivative financial instruments designated as hedging instruments for the three and six months ended January 31, 2014 and January 31, 2013 are presented as follows:
		Amount of Gain or (Loss)								Location of Gain or		Amount of Gain or (Loss) Reclassified from
		Recognized in OCI on Derivatives								(Loss) Reclassified		Accumulated OCI into Earnings
		(Effective Portion)								from Accumulated		(Effective Portion) (b)
										OCI into Earnings
										(Effective Portion)
		Three Months Ended										Three Months Ended
		Jan 31, 2014				Jan 31, 2013						Jan 31, 2014			Jan 31, 2013
	Nonderivatives designated as hedging relationships
	Net investment hedge	$	(3,735	)		$	9,100			N/A		$	—		$	—
		Amount of Gain or (Loss)								Location of Gain or		Amount of Gain or (Loss) Reclassified from
		Recognized in OCI on Derivatives								(Loss) Reclassified		Accumulated OCI into Earnings
		(Effective Portion)								from Accumulated		(Effective Portion) (b)
										OCI into Earnings
										(Effective Portion)
		Six Months Ended										Six Months Ended
		Jan 31, 2014				Jan 31, 2013						Jan 31, 2014			Jan 31, 2013
	Nonderivatives designated as hedging relationships
	Net investment hedge	$	(4,176	)		$	10,437			N/A		$	—		$	—
	(b)	There were no gains or losses recognized in earnings related to the ineffective portion of the hedging relationship or related to the amount excluded from the assessment of hedge effectiveness for the three and six months ended January 31, 2014 and January 31, 2013.

ACCUMULATED_OTHER_COMPREHENSIV1

ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS) (Tables)	6 Months Ended
	Jan. 31, 2014
Accumulated Other Comprehensive Income/(Loss) [Abstract]	'
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	'
	Changes in accumulated other comprehensive income by component are presented below:
		Foreign Currency Translation			Defined Benefit Pension Plan			Unrealized investment gains/(losses)			Unrealized gains/(losses) on derivatives			Accumulated other comprehensive income/(loss)
	Balance at July 31, 2013	$	84,598		$	(125,211	)	$	2,123		$	(2,302	)	$	(40,792	)
	Other comprehensive income/(loss) before reclassifications	21,289			—			(450		)	4,817			25,656
	Amounts reclassified from accumulated other comprehensive income (loss)	—			4,330			76			764			5,170
	Foreign exchange adjustments and other	—			(4,995		)	—			—			(4,995		)
	Balance at January 31, 2014	$	105,887		$	(125,876	)	$	1,749		$	3,279		$	(14,961	)
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]	'
	Reclassifications out of accumulated other comprehensive income are presented below:
		Three Months Ended			Six Months Ended			Affected line item in the Condensed Consolidated Statement of Earnings
		31-Jan-14			31-Jan-14
	Defined Benefit Pension Plan
	Amortization of prior service cost	$	(385	)	$	(769	)	Note (a)
	Recognized actuarial gain/(loss)	(2,770		)	(5,500		)	Note (a)
	Total before tax	(3,155		)	(6,269		)
	Tax benefit	974			1,939
	Net of tax	$	(2,181	)	$	(4,330	)
	Unrealized investment gains/(losses)
	Realized investment gain/(losses)	$	(62	)	$	(119	)	Selling, general and administrative
	Tax (expense)/benefit	23			43
	Net of tax	$	(39	)	$	(76	)
	Unrealized gains/(losses) on derivatives
	Foreign exchange forward contracts	$	113		$	112		Sales
	Foreign exchange forward contracts	(46		)	(866		)	Cost of sales
	Total before tax	67			(754		)
	Tax benefit	(24		)	(10		)
	Net of tax	$	43		$	(764	)
	(a)	These accumulated other comprehensive income components are included in the computation of net periodic pension cost (see Note 8, Components of Net Periodic Pension Cost, for additional details).

SEGMENT_INFORMATION_Tables

SEGMENT INFORMATION (Tables)	6 Months Ended
	Jan. 31, 2014
Segment Reporting [Abstract]	'
Segment Information	'
	The following table presents sales and segment profit from continuing operations by business segment reconciled to earnings from continuing operations before income taxes for the three and six months ended January 31, 2014 and January 31, 2013.
		Three Months Ended				Six Months Ended
		Jan 31, 2014		Jan 31, 2013		Jan 31, 2014		Jan 31, 2013
	SALES:
	Life Sciences	$	353,230	$	329,182	$	672,176	$	629,133
	Industrial	323,739		333,273		634,572		660,922
	Total	$	676,969	$	662,455	$	1,306,748	$	1,290,055
	SEGMENT PROFIT:
	Life Sciences	$	90,856	$	82,477	$	163,901	$	152,319
	Industrial	46,891		48,104		97,373		100,870
	Total segment profit	137,747		130,581		261,274		253,189
	Corporate Services Group	14,766		18,026		30,730		32,091
	ROTC	9,170		4,399		18,368		8,673
	Interest expense, net	5,195		6,017		11,172		5,449
	Earnings from continuing operations before income taxes	$	108,616	$	102,139	$	201,004	$	206,976

DISCONTINUED_OPERATIONS_Tables

DISCONTINUED OPERATIONS (Tables)	6 Months Ended
	Jan. 31, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures	'
	The key components of discontinued operations for the three and six months ended January 31, 2013 were as follows:
		Three Months Ended			Six Months Ended
		Jan 31, 2013			Jan 31, 2013
	Net sales	$	5,496		$	8,523
	Earnings/(loss) from discontinued operations before income taxes	$	(5,663	)	$	394,321
	Provision/(benefit) for income taxes	(2,114		)	147,563
	Earnings/(loss) from discontinued operations, net of income taxes	$	(3,549	)	$	246,758
	Included in earnings from discontinued operations before income taxes above are a (loss)/gain on the sale of the Product Line of $(2,945) and $397,338, respectively, for the three and six months ended January 31, 2013.

BALANCE_SHEET_DETAILS_Details

BALANCE SHEET DETAILS (Details) (USD $)	Jan. 31, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Receivables [Abstract]	'	'
Billed	$482,809	$508,448
Unbilled	67,548	72,787
Total	550,357	581,235
Less: Allowances for doubtful accounts	-13,602	-14,900
Accounts receivable	$536,755	$566,335

BALANCE_SHEET_DETAILS_Details_

BALANCE SHEET DETAILS (Details 1) (USD $)	Jan. 31, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Inventory, Net [Abstract]	'	'
Raw materials and components	$114,702	$94,837
Work-in-process	105,484	94,998
Finished goods	174,679	191,212
Inventory	$394,865	$381,047

BALANCE_SHEET_DETAILS_Details_1

BALANCE SHEET DETAILS (Details 2) (USD $)	Jan. 31, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Property, Plant and Equipment [Abstract]	'	'
Property, plant and equipment	$1,719,826	$1,650,274
Less: Accumulated depreciation and amortization	-930,484	-875,326
Property, plant and equipment	$789,342	$774,948

GOODWILL_AND_INTANGIBLE_ASSETS2

GOODWILL AND INTANGIBLE ASSETS (Details) (USD $)	Jan. 31, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Goodwill [Line Items]	'	'
Goodwill	$348,080	$342,492
Life Sciences [Member]	'	'
Goodwill [Line Items]	'	'
Goodwill	186,098	180,896
Industrial [Member]	'	'
Goodwill [Line Items]	'	'
Goodwill	$161,982	$161,596

GOODWILL_AND_INTANGIBLE_ASSETS3

GOODWILL AND INTANGIBLE ASSETS (Details 1) (USD $)	Jan. 31, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]	'	'
Gross	$235,840	$238,439
Accumulated Amortization	98,455	101,196
Net	137,385	137,243
Patents and unpatented technology [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross	112,559	123,707
Accumulated Amortization	62,044	69,992
Net	50,515	53,715
Customer-related intangibles [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross	106,290	97,016
Accumulated Amortization	27,354	22,425
Net	78,936	74,591
Trademarks [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross	13,353	13,291
Accumulated Amortization	6,573	6,166
Net	6,780	7,125
Other [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross	3,638	4,425
Accumulated Amortization	2,484	2,613
Net	$1,154	$1,812

GOODWILL_AND_INTANGIBLE_ASSETS4

GOODWILL AND INTANGIBLE ASSETS (Details Textuals) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'	'	'	'
Amortization expense for Intangible assets	$4,655	$4,857	$9,379	$10,135
Estimated amortization expense for intangible assets, remainder of 2014	9,296	'	9,296	'
Estimated amortization expense for intangible assets, 2015	17,011	'	17,011	'
Estimated amortization expense for intangible assets, 2016	15,744	'	15,744	'
Estimated amortization expense for intangible assets, 2017	15,662	'	15,662	'
Estimated amortization expense for intangible assets, 2018	15,493	'	15,493	'
Estimated amortization expense for intangible assets, 2019	$13,170	'	$13,170	'

TREASURY_STOCK_Details

TREASURY STOCK (Details) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jul. 31, 2013
Stock Repurchase Program [Roll Forward]	'	'
Amount available for repurchases as of July 31, 2013	$81,873	$331,873
New authorizations	0	'
Utilized	250,000	'
Amount available for repurchases as of January 31, 2014	81,873	331,873
September 26, 2011 Authorization [Member]	'	'
Stock Repurchase Program [Roll Forward]	'	'
Amount available for repurchases as of July 31, 2013	0	81,873
New authorizations	0	'
Utilized	81,873	'
Amount available for repurchases as of January 31, 2014	0	81,873
January 17, 2013 Authorization [Member]	'	'
Stock Repurchase Program [Roll Forward]	'	'
Amount available for repurchases as of July 31, 2013	81,873	250,000
New authorizations	0	'
Utilized	168,127	'
Amount available for repurchases as of January 31, 2014	$81,873	$250,000

TREASURY_STOCK_Detail_Textuals

TREASURY STOCK (Detail Textuals) (USD $)	6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jan. 31, 2014
Accelerated Share Repurchases [Line Items]	'
Stock Repurchase Program, Amount Utilized	$250,000
Shares issued for stock plans	694
Treasury stock, shares	18,298
September 2013 Accelerated Share Repurchase [Member]	'
Accelerated Share Repurchases [Line Items]	'
Stock Repurchase Program, Amount Utilized	125,000
Total number of shares repurchased (in shares)	1,573
Accelerated Share Repurchases, Final Price Paid Per Share	$79.45
December 2013 Accelerated Share Repurchase [Member]	'
Accelerated Share Repurchases [Line Items]	'
Stock Repurchase Program, Amount Utilized	125,000
Total number of shares repurchased (in shares)	1,249
Aggregate cost of shares repurchased in the period	106,250
Accelerated Share Repurchases, Initial Price Paid Per Share	$85.05
ASR Amount Included in Additional Paid in Capital to be Reclassified to Treasury Stock	$18,750

CONTINGENCIES_AND_COMMITMENTS_

CONTINGENCIES AND COMMITMENTS (Details Textuals) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014
Site Contingency [Line Items]	'
Environmental liabilities	$21,402
Pinellas Park Site [Member]	'
Site Contingency [Line Items]	'
Environmental matters	$4,440

RESTRUCTURING_AND_OTHER_CHARGE2

RESTRUCTURING AND OTHER CHARGES, NET (Details) (USD $)	3 Months Ended				6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014		Jan. 31, 2013		Jan. 31, 2014		Jan. 31, 2013
Restructuring Charges [Abstract]	'		'		'		'
Restructuring, Severance Benefits and Other Employment Contract Obligations	$7,347	[1]	$1,916	[1]	$10,462	[1]	$5,195	[1]
Professional fees and other costs, net of receipt of insurance claim payments	894	[1]	345	[1]	2,137	[1]	788	[1]
(Gain)/loss on sale and impairment of assets, net	0	[1]	-49	[1]	0	[1]	-6	[1]
Reversal of excess restructuring reserves	-280	[1]	-151	[1]	-624	[1]	-341	[1]
Restructuring Charges	7,961	[1]	2,061	[1]	11,975	[1]	5,636	[1]
Cash	7,961	[1]	1,705	[1]	11,975	[1]	5,237	[1]
Non-cash	0	[1]	356	[1]	0	[1]	399	[1]
Other Gains (Charges) [Abstract]	'		'		'		'
Severance benefits and other employment contract obligations	-844	[2]	1,451	[2]	-402	[2]	1,451	[2]
Professional fees and other costs, net of receipt of insurance claim payments	2,053	[2]	887	[2]	2,195	[2]	1,586	[2]
(Gain)/loss on sale and impairment of assets, net	0	[2]	0	[2]	160	[2]	0	[2]
Environmental matters	'		'		4,440	[2]	'
Other Gains (Charges)	1,209	[2]	2,338	[2]	6,393	[2]	3,037	[2]
Cash	1,209	[2]	1,825	[2]	6,233	[2]	2,524	[2]
Non-cash	0	[2]	513	[2]	160	[2]	513	[2]
Restructuring Charges and Other Gains (Charges) [Abstract]	'		'		'		'
Restructuring and Other Gains (Charges), Severance Benefits and Other Employment Contract Obligations	-6,503		-3,367		-10,060		-6,646
Restructuring and Other Gains (Charges), Professional Services and Costs Net of Insurance	-2,947		-1,232		-4,332		-2,374
(Gain)/loss on sale and impairment of assets, net	0		-49		160		-6
Environmental matters	'		'		4,440	[2]	'
Reversal of excess restructuring reserves	-280	[1]	-151	[1]	-624	[1]	-341	[1]
Restructuring And Other Gains (Charges)	-9,170		-4,399		-18,368		-8,673
Cash	9,170		3,530		18,208		7,761
Non-cash	$0		$869		$160		$912
[1]	Restructuring:In fiscal year 2012, the Company announced a multi-year strategic cost reduction initiative (“structural cost improvement initiative”). This initiative impacts both segments as well as the Corporate Services Group. The goal of this initiative is to properly position the Company’s cost structure globally to perform in the current economic environment without adversely impacting its growth or innovation potential. Key components of the structural cost improvement initiative include:•the strategic alignment of manufacturing, sales and R&D facilities to cost-effectively deliver high-quality products and superior service to the Company’s customers worldwide,•creation of regional shared financial services centers for the handling of accounting transaction processing and other accounting functions,•reorganization of sales functions, to more cost-efficiently deliver superior service to the Company’s customers globally, and•reductions in headcount across all functional areas, enabled by efficiencies gained through the Company’s ERP systems, as well as in order to align to economic conditions.Restructuring charges recorded in the three and six months ended January 31, 2014 and January 31, 2013 primarily reflect the expenses incurred in connection with the Company’s structural cost improvement initiative as discussed above.
[2]	Other (Gains)/Charges:Severance benefits and other employment contract obligations: In the three months ended January 31, 2013, the Company recorded charges related to certain employment contract obligations.Professional fees and other: In the three months ended January 31, 2014, the Company recorded acquisition related legal and other professional fees. In the three and six months ended January 31, 2013, the Company recorded settlement related costs as well as legal and other professional fees, related to the Federal Securities Class Actions, Shareholder Derivative Lawsuits and Other Proceedings (see Note 14, Contingencies and Commitments, in the 2013 Form 10-K). The receipt of insurance claim payments partly offset these costs for the six months ended January 31, 2013.Environmental matters: As discussed in Note 5, Contingencies and Commitments, in the six months ended January 31, 2014, the Company increased its previously established environmental reserve related to a matter in Pinellas Park, Florida.

RESTRUCTURING_AND_OTHER_CHARGE3

RESTRUCTURING AND OTHER CHARGES, NET (Details 1) (USD $)

3 Months Ended

6 Months Ended

12 Months Ended

6 Months Ended

12 Months Ended

6 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Jan. 31, 2014

Jan. 31, 2013

Jan. 31, 2014

Jan. 31, 2013

Jan. 31, 2014

Jul. 31, 2013

Jul. 31, 2012

Jan. 31, 2014

Jul. 31, 2013

Jul. 31, 2012

Jan. 31, 2014

Jul. 31, 2013

Jul. 31, 2012

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Structural Cost Improvement Initiative [Member]

Severance [Member]

Severance [Member]

Severance [Member]

Other Restructuring [Member]

Other Restructuring [Member]

Other Restructuring [Member]

Restructuring Reserve [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

'

'

Original charge

$7,961

[1]

$2,061

[1]

$11,975

[1]

$5,636

[1]

'

'

$65,300

'

'

$61,852

'

'

$3,448

Utilized

'

'

'

'

-14,379

-31,510

-30,163

-12,787

-29,574

-27,365

-1,592

-1,936

-2,798

Translation

'

'

'

'

342

336

-170

306

313

-123

36

23

-47

Restructuring Reserve

'

'

'

'

27,713

34,967

'

26,240

34,364

'

1,473

603

'

Additions

'

'

'

'

12,599

24,477

'

10,462

21,637

'

2,137

2,840

'

Reversal of excess restructuring reserves

280

[1]

151

[1]

624

[1]

341

[1]

-624

-557

'

-506

-500

'

-118

-57

'

Restructuring Reserve

'

'

'

'

$25,651

$27,713

$34,967

$23,715

$26,240

$34,364

$1,936

$1,473

$603

[1]

Restructuring:In fiscal year 2012, the Company announced a multi-year strategic cost reduction initiative (“structural cost improvement initiative”). This initiative impacts both segments as well as the Corporate Services Group. The goal of this initiative is to properly position the Company’s cost structure globally to perform in the current economic environment without adversely impacting its growth or innovation potential. Key components of the structural cost improvement initiative include:•the strategic alignment of manufacturing, sales and R&D facilities to cost-effectively deliver high-quality products and superior service to the Company’s customers worldwide,•creation of regional shared financial services centers for the handling of accounting transaction processing and other accounting functions,•reorganization of sales functions, to more cost-efficiently deliver superior service to the Company’s customers globally, and•reductions in headcount across all functional areas, enabled by efficiencies gained through the Company’s ERP systems, as well as in order to align to economic conditions.Restructuring charges recorded in the three and six months ended January 31, 2014 and January 31, 2013 primarily reflect the expenses incurred in connection with the Company’s structural cost improvement initiative as discussed above.

RESTRUCTURING_AND_OTHER_CHARGE4

RESTRUCTURING AND OTHER CHARGES, NET (Details Textuals) (Restructuring Liability 2009 And 2010 [Member], USD $)	Jan. 31, 2014
In Thousands, unless otherwise specified
Restructuring Liability 2009 And 2010 [Member]	'
Restructuring and other gains charges [Line Items]	'
Restructuring Reserve	$216

INCOME_TAXES_Details_Textuals

INCOME TAXES (Details Textuals) (USD $)	6 Months Ended			6 Months Ended	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jul. 31, 2013	Jan. 31, 2013	Jan. 31, 2014
				Internal Revenue Service (IRS) [Member]	United Kingdom [Member]
					Tax Audit Resolution - February 3, 2014 [Member]
Income Tax Examination [Line Items]	'	'	'	'	'
Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority	'	'	'	$10,193	$8,000
Reversal of Interest Due to Audit Settlement	'	'	'	6,704	1,000
Reversal of Interest, Net of Income Tax, Due to Audit Settlement	'	'	'	4,268	'
Effective Income Tax Rate, Continuing Operations	22.80%	18.10%	'	'	'
Discrete Tax Item	'	7,757	'	'	'
Unrecognized Tax Benefits	211,463	'	203,376	'	'
Unrecognized Tax Benefits, Period Increase (Decrease)	8,087	'	'	'	'
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	163,188	'	'	'	'
Income Tax Examination, Penalties and Interest Accrued	20,767	'	18,622	'	'
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Lower Bound	0	'	'	'	'
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Upper Bound	$66,183	'	'	'	'

COMPONENTS_OF_NET_PERIODIC_PEN2

COMPONENTS OF NET PERIODIC PENSION COST (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Service cost	$3,167	$3,808	$6,333	$7,645
Interest cost	7,348	6,666	14,580	13,301
Expected return on plan assets	-5,866	-6,502	-11,629	-12,988
Amortization of prior service cost/(credit)	385	378	769	754
Amortization of actuarial loss	2,770	3,823	5,500	7,634
Loss due to curtailments and settlements	0	17	0	33
Net periodic benefit cost	7,804	8,190	15,553	16,379
U.S. Plans [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Service cost	2,170	2,647	4,340	5,295
Interest cost	3,027	2,618	6,055	5,235
Expected return on plan assets	-2,324	-2,384	-4,649	-4,767
Amortization of prior service cost/(credit)	395	393	790	786
Amortization of actuarial loss	1,345	2,411	2,689	4,822
Loss due to curtailments and settlements	0	17	0	33
Net periodic benefit cost	4,613	5,702	9,225	11,404
Foreign Plans [Member]	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Service cost	997	1,161	1,993	2,350
Interest cost	4,321	4,048	8,525	8,066
Expected return on plan assets	-3,542	-4,118	-6,980	-8,221
Amortization of prior service cost/(credit)	-10	-15	-21	-32
Amortization of actuarial loss	1,425	1,412	2,811	2,812
Loss due to curtailments and settlements	0	0	0	0
Net periodic benefit cost	$3,191	$2,488	$6,328	$4,975

STOCKBASED_PAYMENT_Details

STOCK-BASED PAYMENT (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Number of Share Based Employee and Director Compensation Award Types	4	'	4	'
Allocated Share-based Compensation Expense	$9,464	$7,392	$15,595	$13,072
Restricted stock units [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Allocated Share-based Compensation Expense	6,254	4,609	10,447	7,917
Stock options [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Allocated Share-based Compensation Expense	1,965	1,544	3,486	2,678
Management Stock Purchase Plan [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Allocated Share-based Compensation Expense	972	937	1,164	1,787
Employee Stock [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'
Allocated Share-based Compensation Expense	$273	$302	$498	$690

EARNINGS_PER_SHARE_Details

EARNINGS PER SHARE (Details)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]	'	'	'	'
Basic shares outstanding	110,720	112,420	111,263	113,398
Effect of stock plans	1,260	1,389	1,269	1,386
Diluted shares outstanding	111,980	113,809	112,532	114,784

EARNINGS_PER_SHARE_Details_Tex

EARNINGS PER SHARE (Details Textuals)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Earnings Per Share [Abstract]	'	'	'	'
Employee stock options and restricted stock units which were not included in the computation of diluted shares	506	1,254	921	1,175

FAIR_VALUE_MEASUREMENTS_Detail

FAIR VALUE MEASUREMENTS (Details) (USD $)	Jan. 31, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Available-for-sale securities:	'	'
Securities	$68,632	$70,744
Trading Securities [Abstract]	'	'
Trading Securities	216	190
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'	'
Trading Securities [Abstract]	'	'
Trading Securities	216	190
Derivative financial instruments:	'	'
Foreign exchange forward contracts	4,512	301
Derivative financial instruments:	'	'
Foreign exchange forward contracts	1,683	3,066
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member] | Equity Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	203	176
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member] | Corporate Debt Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	30,191	32,393
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member] | U.S. Treasury [Member]	'	'
Available-for-sale securities:	'	'
Securities	10,793	11,543
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member] | Federal Agency [Member]	'	'
Available-for-sale securities:	'	'
Securities	18,574	20,642
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member] | Mortgage-backed [Member]	'	'
Available-for-sale securities:	'	'
Securities	8,171	5,990
Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member] | Commercial Paper [Member]	'	'
Available-for-sale securities:	'	'
Securities	700	'
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]	'	'
Trading Securities [Abstract]	'	'
Trading Securities	216	190
Derivative financial instruments:	'	'
Foreign exchange forward contracts	0	0
Derivative financial instruments:	'	'
Foreign exchange forward contracts	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Equity Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	203	176
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Corporate Debt Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | U.S. Treasury [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Federal Agency [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Mortgage-backed [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Commercial Paper [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	'
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]	'	'
Trading Securities [Abstract]	'	'
Trading Securities	0	0
Derivative financial instruments:	'	'
Foreign exchange forward contracts	4,512	301
Derivative financial instruments:	'	'
Foreign exchange forward contracts	1,683	3,066
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Equity Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Corporate Debt Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	30,191	32,393
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | U.S. Treasury [Member]	'	'
Available-for-sale securities:	'	'
Securities	10,793	11,543
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Federal Agency [Member]	'	'
Available-for-sale securities:	'	'
Securities	18,574	20,642
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Mortgage-backed [Member]	'	'
Available-for-sale securities:	'	'
Securities	8,171	5,990
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Commercial Paper [Member]	'	'
Available-for-sale securities:	'	'
Securities	700	'
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]	'	'
Trading Securities [Abstract]	'	'
Trading Securities	0	0
Derivative financial instruments:	'	'
Foreign exchange forward contracts	0	0
Derivative financial instruments:	'	'
Foreign exchange forward contracts	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Equity Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Corporate Debt Securities [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | U.S. Treasury [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Federal Agency [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Mortgage-backed [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Commercial Paper [Member]	'	'
Available-for-sale securities:	'	'
Securities	0	'
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]	'	'
Financial assets carried at fair value	'	'
Money market funds	2,469	6,404
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]	'	'
Financial assets carried at fair value	'	'
Money market funds	2,469	6,404
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]	'	'
Financial assets carried at fair value	'	'
Money market funds	0	0
Money Market Funds [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]	'	'
Financial assets carried at fair value	'	'
Money market funds	$0	$0

INVESTMENT_SECURITIES_Details

INVESTMENT SECURITIES (Details) (USD $)	Jan. 31, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Schedule of Available-for-sale Securities [Line Items]	'	'
Cost/ Amortized Cost Basis	$67,064	$68,623
Fair Value	68,632	70,744
Gross Unrealized Holding Gains	2,572	2,937
Gross Unrealized Holding Losses	-1,004	-816
Net Unrealized Holding Gains/(Losses)	1,568	2,121
Equity Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Equity Securities, Cost/Amortized Cost Basis	197	176
Equity Securities, Fair Value	203	176
Equity Securities, Gross Unrealized Holding Gains	6	0
Equity Securities, Gross Unrealized Holdings Losses	0	0
Equity Securities, Net Unrealized Holding Gains/(Losses)	6	0
Corporate Debt Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Debt Securities, Cost/Amortized Cost Basis	29,452	31,546
Debt Securities, Fair Value	30,191	32,393
Debt Securities, Gross Unrealized Holding Gains	1,168	1,274
Debt Securities, Gross Unrealized Holdings Losses	-429	-427
Debt Securities, Net Unrealized Holding Gains/(Losses)	739	847
U.S. Treasury [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Debt Securities, Cost/Amortized Cost Basis	10,741	11,339
Debt Securities, Fair Value	10,793	11,543
Debt Securities, Gross Unrealized Holding Gains	206	294
Debt Securities, Gross Unrealized Holdings Losses	-154	-90
Debt Securities, Net Unrealized Holding Gains/(Losses)	52	204
Federal Agency [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Debt Securities, Cost/Amortized Cost Basis	17,978	19,810
Debt Securities, Fair Value	18,574	20,642
Debt Securities, Gross Unrealized Holding Gains	1,002	1,131
Debt Securities, Gross Unrealized Holdings Losses	-406	-299
Debt Securities, Net Unrealized Holding Gains/(Losses)	596	832
Mortgage-backed [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Debt Securities, Cost/Amortized Cost Basis	7,997	5,752
Debt Securities, Fair Value	8,171	5,990
Debt Securities, Gross Unrealized Holding Gains	189	238
Debt Securities, Gross Unrealized Holdings Losses	-15	0
Debt Securities, Net Unrealized Holding Gains/(Losses)	174	238
Commercial Paper [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Debt Securities, Cost/Amortized Cost Basis	699	'
Debt Securities, Fair Value	700	'
Debt Securities, Gross Unrealized Holding Gains	1	'
Debt Securities, Gross Unrealized Holdings Losses	0	'
Debt Securities, Net Unrealized Holding Gains/(Losses)	$1	'

INVESTMENT_SECURITIES_Details_

INVESTMENT SECURITIES (Details 1) (USD $)	Jan. 31, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Schedule of Available-for-sale Securities [Line Items]	'	'
Less than 12 months, Fair Value	$20,730	$18,469
Less than 12 months, Gross Unrealized Holding Losses	-1,004	-816
12 months or greater, Fair Value	0	0
12 months or greater, Gross Unrealized Holding Losses	0	0
Total, Fair Value	20,730	18,469
Total, Gross Unrealized Holding Losses	-1,004	-816
Corporate Debt Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Less than 12 months, Fair Value	9,685	10,990
Less than 12 months, Gross Unrealized Holding Losses	-429	-427
12 months or greater, Fair Value	0	0
12 months or greater, Gross Unrealized Holding Losses	0	0
Total, Fair Value	9,685	10,990
Total, Gross Unrealized Holding Losses	-429	-427
U.S. Treasury [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Less than 12 months, Fair Value	4,328	3,778
Less than 12 months, Gross Unrealized Holding Losses	-154	-90
12 months or greater, Fair Value	0	0
12 months or greater, Gross Unrealized Holding Losses	0	0
Total, Fair Value	4,328	3,778
Total, Gross Unrealized Holding Losses	-154	-90
Federal Agency [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Less than 12 months, Fair Value	3,785	3,701
Less than 12 months, Gross Unrealized Holding Losses	-406	-299
12 months or greater, Fair Value	0	0
12 months or greater, Gross Unrealized Holding Losses	0	0
Total, Fair Value	3,785	3,701
Total, Gross Unrealized Holding Losses	-406	-299
Mortgage-backed [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Less than 12 months, Fair Value	2,932	'
Less than 12 months, Gross Unrealized Holding Losses	-15	'
12 months or greater, Fair Value	0	'
12 months or greater, Gross Unrealized Holding Losses	0	'
Total, Fair Value	2,932	'
Total, Gross Unrealized Holding Losses	($15)	'

INVESTMENT_SECURITIES_Details_1

INVESTMENT SECURITIES (Details 2) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Investments, Debt and Equity Securities [Abstract]	'	'	'	'
Proceeds from sales	$2,558	$6,689	$3,058	$12,286
Realized gross gains on sales	84	160	84	352
Realized gross losses on sales	$99	$3	$100	$5

INVESTMENT_SECURITIES_Details_2

INVESTMENT SECURITIES (Details 3) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013	Jul. 31, 2013
Investments, Debt and Equity Securities [Abstract]	'	'	'	'	'
Equity securities	$216	'	$216	'	$190
Total trading securities	216	'	216	'	190
Gains, net recognized for securities held	7	0	23	0	'
Gains, net recognized for securities sold	0	0	0	0	'
Total gains, net recognized	$7	$0	$23	$0	'

DERIVATIVE_INSTRUMENTS_AND_HED2

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details Textuals)	Jan. 31, 2014	Jan. 31, 2014	Jan. 31, 2014	Jan. 31, 2014	Jan. 31, 2014	Jan. 31, 2014
	USD ($)	Foreign Exchange Contract [Member]	Not Designated as Hedging Instrument [Member]	Not Designated as Hedging Instrument [Member]	Designated as Hedging Instrument [Member]	Unsecured Debt [Member]
		USD ($)	Foreign Exchange Contract [Member]	Foreign Exchange Contract [Member]	Cash Flow Hedging [Member]	Jpy Loan Due Fiscal Year 2015 [Member]
			USD ($)	USD ($)	Foreign Exchange Contract [Member]	JPY (¥)
					USD ($)
Derivative [Line Items]	'	'	'	'	'	'
Derivative, Notional Amount	'	$477,156,000	$369,219,000	$369,219,000	$107,937,000	'
Foreign Currency Derivatives at Fair Value, Net	2,829,000	'	'	'	'	'
Debt Instrument, Face Amount	'	'	'	'	'	9,000,000,000
Derivative, Notional Amount Entered During Period	'	'	$607,273,000	$1,181,442,000	$54,767,000	'

DERIVATIVE_INSTRUMENTS_AND_HED3

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details) (USD $)	Jan. 31, 2014	Jul. 31, 2013
In Thousands, unless otherwise specified
Foreign Exchange Contract [Member] | Other Current Assets [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Foreign exchange forward contracts	$4,512	$301
Foreign Exchange Contract [Member] | Other Current Liabilities [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Foreign exchange forward contracts	1,683	3,066
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member] | Other Current Assets [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Foreign exchange forward contracts	3,567	0
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member] | Other Current Liabilities [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Foreign exchange forward contracts	4	1,941
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | Other Current Assets [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Foreign exchange forward contracts	945	301
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | Other Current Liabilities [Member]	'	'
Derivatives, Fair Value [Line Items]	'	'
Foreign exchange forward contracts	1,679	1,125
Net Investment Hedging [Member] | Long-term Debt [Member]	'	'
Nonderivative instruments designated as hedging instruments	'	'
Debt Instrument, Fair Value Disclosure	$87,624	$91,800

DERIVATIVE_INSTRUMENTS_AND_HED4

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details 1) (Designated as Hedging Instrument [Member], Foreign Exchange Contract [Member], Cash Flow Hedging [Member], USD $)	3 Months Ended				6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014		Jan. 31, 2013		Jan. 31, 2014		Jan. 31, 2013
Derivative Instruments, Gain (Loss) [Line Items]	'		'		'		'
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion)	$67	[1]	($466)	[1]	($754)	[1]	($557)	[1]
Sales [Member]	'		'		'		'
Derivative Instruments, Gain (Loss) [Line Items]	'		'		'		'
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion)	113	[1]	-296	[1]	112	[1]	-387	[1]
Cost of Sales [Member]	'		'		'		'
Derivative Instruments, Gain (Loss) [Line Items]	'		'		'		'
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Earnings (Effective Portion)	-46	[1]	-170	[1]	-866	[1]	-170	[1]
Other Comprehensive Income (Loss) [Member]	'		'		'		'
Derivative Instruments, Gain (Loss) [Line Items]	'		'		'		'
Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion)	$3,489		($1,825)		$5,310		($3,777)
[1]	There were no gains or losses recognized in earnings related to the ineffective portion of the hedging relationship or related to the amount excluded from the assessment of hedge effectiveness for the three and six months ended January 31, 2014 and January 31, 2013.

DERIVATIVE_INSTRUMENTS_AND_HED5

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details 2) (Not Designated as Hedging Instrument [Member], Foreign Exchange Contract [Member], Selling, General and Administrative Expenses [Member], USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member] | Selling, General and Administrative Expenses [Member]	'	'	'	'
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments [Abstract]	'	'	'	'
Derivative, Gain (Loss) on Derivative, Net	($2,792)	($7,388)	($2,343)	($9,826)

DERIVATIVE_INSTRUMENTS_AND_HED6

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details 3) (Net Investment Hedging [Member], USD $)	3 Months Ended				6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014		Jan. 31, 2013		Jan. 31, 2014		Jan. 31, 2013
Net Investment Hedging [Member]	'		'		'		'
Nonderivatives designated as hedging relationships	'		'		'		'
Nonderivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion	($3,735)		$9,100		($4,176)		$10,437
Nonderivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion	$0	[1]	$0	[1]	$0	[1]	$0	[1]
[1]	There were no gains or losses recognized in earnings related to the ineffective portion of the hedging relationship or related to the amount excluded from the assessment of hedge effectiveness for the three and six months ended January 31, 2014 and January 31, 2013.

ACCUMULATED_OTHER_COMPREHENSIV2

ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS) (Details) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'
Balance at July 31, 2013	($40,792)
Other comprehensive income/(loss) before reclassifications	25,656
Amounts reclassified from accumulated other comprehensive income (loss)	5,170
Foreign exchange adjustments and other	-4,995
Balance at January 31, 2014	-14,961
Foreign Currency Translation [Member]	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'
Balance at July 31, 2013	84,598
Other comprehensive income/(loss) before reclassifications	21,289
Amounts reclassified from accumulated other comprehensive income (loss)	0
Balance at January 31, 2014	105,887
Defined Benefit Pension Plan [Member]	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'
Balance at July 31, 2013	-125,211
Other comprehensive income/(loss) before reclassifications	0
Amounts reclassified from accumulated other comprehensive income (loss)	4,330
Foreign exchange adjustments and other	-4,995
Balance at January 31, 2014	-125,876
Unrealized investment gains/(losses) [Member]	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'
Balance at July 31, 2013	2,123
Other comprehensive income/(loss) before reclassifications	-450
Amounts reclassified from accumulated other comprehensive income (loss)	76
Balance at January 31, 2014	1,749
Unrealized gains/(losses) on derivatives [Member]	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'
Balance at July 31, 2013	-2,302
Other comprehensive income/(loss) before reclassifications	4,817
Amounts reclassified from accumulated other comprehensive income (loss)	764
Balance at January 31, 2014	$3,279

ACCUMULATED_OTHER_COMPREHENSIV3

ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS) (Details 1) (USD $)	3 Months Ended			6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014		Jan. 31, 2013	Jan. 31, 2014		Jan. 31, 2013
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'		'	'		'
Total before tax	$108,616		$102,139	$201,004		$206,976
Realized investment gain/(losses)	-196,299		-206,009	-391,183		-401,974
Tax benefit	-24,950		-21,820	-45,825		-37,492
Net of tax	83,666		76,770	155,179		416,242
Foreign exchange forward contracts	676,969		662,455	1,306,748		1,290,055
Foreign exchange forward contracts	-332,710		-320,492	-636,775		-621,009
Accumulated Defined Benefit Plans Adjustment [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'		'	'		'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'		'	'		'
Amortization of prior service cost	-385	[1]	'	-769	[1]	'
Recognized actuarial gain/(loss)	-2,770	[1]	'	-5,500	[1]	'
Total before tax	-3,155		'	-6,269		'
Tax benefit	974		'	1,939		'
Net of tax	-2,181		'	-4,330		'
Accumulated Net Unrealized Investment Gain (Loss) [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'		'	'		'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'		'	'		'
Realized investment gain/(losses)	-62		'	-119		'
Tax benefit	23		'	43		'
Net of tax	-39		'	-76		'
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'		'	'		'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'		'	'		'
Total before tax	67		'	-754		'
Tax benefit	-24		'	-10		'
Net of tax	43		'	-764		'
Foreign Exchange Contract [Member] | Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]	'		'	'		'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'		'	'		'
Foreign exchange forward contracts	113		'	112		'
Foreign exchange forward contracts	($46)		'	($866)		'
[1]	These accumulated other comprehensive income components are included in the computation of net periodic pension cost (see Note 8, Components of Net Periodic Pension Cost, for additional details).

SEGMENT_INFORMATION_Details

SEGMENT INFORMATION (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Segment Reporting Information, Revenue for Reportable Segment [Abstract]	'	'	'	'
Net sales	$676,969	$662,455	$1,306,748	$1,290,055
Operating Income (Loss) [Abstract]	'	'	'	'
ROTC	9,170	4,399	18,368	8,673
Interest expense, net	5,195	6,017	11,172	5,449
Earnings from continuing operations before income taxes	108,616	102,139	201,004	206,976
Operating Segments [Member]	'	'	'	'
Operating Income (Loss) [Abstract]	'	'	'	'
Operating Income (Loss)	137,747	130,581	261,274	253,189
Corporate, Non-Segment [Member]	'	'	'	'
Operating Income (Loss) [Abstract]	'	'	'	'
Operating Income (Loss)	-14,766	-18,026	-30,730	-32,091
Segment Reconciling Items [Member]	'	'	'	'
Operating Income (Loss) [Abstract]	'	'	'	'
ROTC	9,170	4,399	18,368	8,673
Interest expense, net	5,195	6,017	11,172	5,449
Life Sciences Segment [Member]	'	'	'	'
Segment Reporting Information, Revenue for Reportable Segment [Abstract]	'	'	'	'
Net sales	353,230	329,182	672,176	629,133
Life Sciences Segment [Member] | Operating Segments [Member]	'	'	'	'
Operating Income (Loss) [Abstract]	'	'	'	'
Operating Income (Loss)	90,856	82,477	163,901	152,319
Industrial Segment [Member]	'	'	'	'
Segment Reporting Information, Revenue for Reportable Segment [Abstract]	'	'	'	'
Net sales	323,739	333,273	634,572	660,922
Industrial Segment [Member] | Operating Segments [Member]	'	'	'	'
Operating Income (Loss) [Abstract]	'	'	'	'
Operating Income (Loss)	$46,891	$48,104	$97,373	$100,870

DISCONTINUED_OPERATIONS_Detail

DISCONTINUED OPERATIONS (Details Textual) (Product Line [Member], USD $)	1 Months Ended	3 Months Ended	6 Months Ended
	Aug. 31, 2012	Jan. 31, 2013	Jan. 31, 2013	Apr. 28, 2012
	employee
Product Line [Member]	'	'	'	'
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'	'
Expected proceeds from divestiture of component	'	'	'	$550,000,000
Number of employees to be transferred	1,400	'	'	'
Proceeds From divestiture of component	535,000,000	'	'	'
Gain (loss) on the sale of product line	'	($2,945,000)	$397,338,000	'

DISCONTINUED_OPERATIONS_Detail1

DISCONTINUED OPERATIONS (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Jan. 31, 2014	Jan. 31, 2013
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'	'
Earnings/(loss) from discontinued operations, net of income taxes	$0	($3,549)	$0	$246,758
Product Line [Member]	'	'	'	'
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'	'
Net sales	'	5,496	'	8,523
Earnings/(loss) from discontinued operations before income taxes	'	-5,663	'	394,321
Provision/(benefit) for income taxes	'	-2,114	'	147,563
Earnings/(loss) from discontinued operations, net of income taxes	'	($3,549)	'	$246,758

SUBSEQUENT_EVENT_Details

SUBSEQUENT EVENT (Details) (ATMI LifeSciences [Member], USD $)	6 Months Ended	3 Months Ended
In Millions, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2014
		Date of acquisition - February 20, 2014 [Member]
Subsequent Event [Line Items]	'	'
Business Acquisition, Name of Acquired Entity	'	'ATMI LifeSciences
Payments to Acquire Businesses, Gross	$185	'